Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
negative regulation of apoptotic process (GO:0043066),17/485,1.9307401034243822e-8,2.060440913926164e-5,0,0,6.181905083220872,109.80780353809142,BNIP3L;NPM1;SET;TFRC;HSPD1;PRDX2;HNRNPK;UBB;MYC;BAG1;CAT;PIM1;UBA52;PTMA;BCL2L1;CPEB4;SNCA
negative regulation of programmed cell death (GO:0043069),15/381,3.084492386117012e-8,2.060440913926164e-5,0,0,6.890545505935557,119.1671173381832,BNIP3L;NPM1;TFRC;HSPD1;PRDX2;HNRNPK;UBB;MYC;BAG1;CAT;PIM1;UBA52;PTMA;BCL2L1;SNCA
regulation of apoptotic process (GO:0042981),19/742,3.732223974615912e-7,1.6620837433622862e-4,0,0,4.4923681090693535,66.49195078325097,BNIP3L;HSP90AA1;NPM1;ARHGEF12;TFRC;FOXO3;HSPD1;PRDX2;HNRNPK;UBB;MYC;BAG1;CAT;TP53INP1;PIM1;UBA52;PTMA;BCL2L1;SNCA
response to unfolded protein (GO:0006986),6/49,7.811326203449899e-7,2.6089829519522663e-4,0,0,22.131348837209302,311.2225554166756,HSPA8;HSP90AA1;HSP90AB1;STT3B;OPTN;HSPD1
regulation of translation (GO:0006417),9/178,2.6661100966495785e-6,7.123846178247673e-4,0,0,8.599282180618877,110.37084121541159,NPM1;NCL;CAPRIN1;VIM;FOXO3;GAPDH;GSPT1;EIF4G2;EIF1
regulation of mRNA stability (GO:0043488),8/146,5.399539973467245e-6,0.0012022975674253731,0,0,9.299399080947332,112.79424155708121,HSPA8;NPM1;SET;UBB;SERBP1;VIM;UBA52;TENT5C
hydrogen peroxide catabolic process (GO:0042744),4/21,9.649478504555002e-6,0.0018416718974407832,0,0,36.77999073645206,424.7576468951557,PRDX2;CAT;HBA1;HBD
cellular response to cytokine stimulus (GO:0071345),13/482,1.7237334447560925e-5,0.0028786348527426744,0,0,4.557117559900257,49.984438260188504,HSPA8;HSP90AA1;DOCK8;FOXO3;YBX3;UBB;WNK1;MYC;PIM1;VIM;UBA52;GAPDH;BCL2L1
hydrogen peroxide metabolic process (GO:0042743),4/29,3.676990337708452e-5,0.005458287879087214,0,0,25.00031496062992,255.27398827021548,PRDX2;CAT;HBD;HBA1
gas transport (GO:0015669),3/12,5.786206237200637e-5,0.007039947117199915,0,0,51.71875,504.6430455506087,CA2;MYC;HBA1
cytokine-mediated signaling pathway (GO:0019221),14/621,5.7963636444011276e-5,0.007039947117199915,0,0,3.7971247131049437,37.04358944609144,HSPA8;HSP90AA1;MSN;ADIPOR1;FOXO3;CA1;UBB;MYC;CANX;HNRNPA2B1;PIM1;VIM;UBA52;BCL2L1
bicarbonate transport (GO:0015701),4/35,7.863276432528931e-5,0.008754447761548876,0,0,20.15544831089662,190.4835407159334,CA1;CA2;SLC4A1;HBA1
positive regulation of type I interferon production (GO:0032481),5/77,1.5122695529130818e-4,0.01459035361265474,0,0,10.911044973544973,95.98150393191172,HSP90AA1;RIOK3;G3BP1;GAPDH;HSPD1
regulation of mRNA catabolic process (GO:0061013),6/122,1.5289292707871733e-4,0.01459035361265474,0,0,8.173655172413794,71.81187651041928,HSPA8;SET;UBB;SERBP1;VIM;UBA52
positive regulation of cellular biosynthetic process (GO:0031328),7/180,1.859348894339749e-4,0.01656060081891936,0,0,6.4269998135372,55.20866109131433,SLC25A37;HSP90AA1;NPM1;HSP90AB1;MYC;VIM;SNCA
positive regulation of autophagy (GO:0010508),5/90,3.1433074048012484e-4,0.026246616830090424,0,0,9.236227824463118,74.49077602981043,BNIP3L;TP53INP1;FOXO3;FBXO7;OPTN
positive regulation of cellular catabolic process (GO:0031331),6/141,3.349975129387572e-4,0.026326863369775272,0,0,7.016533333333333,56.14200175745505,HSP90AA1;TP53INP1;MSN;FOXO3;OPTN;SNCA
chaperone-mediated protein complex assembly (GO:0051131),3/22,3.860820746745212e-4,0.02807552871305469,0,0,24.486019736842106,192.44690694185442,HSP90AA1;HSP90AB1;HSPD1
cellular response to testosterone stimulus (GO:0071394),2/5,4.2029234600381274e-4,0.02807552871305469,0,0,102.66666666666667,798.1881627629406,NCOA4;MSN
hemoglobin metabolic process (GO:0020027),2/5,4.2029234600381274e-4,0.02807552871305469,0,0,102.66666666666667,798.1881627629406,ALAS2;AHSP
regulation of peptidyl-serine phosphorylation (GO:0033135),5/98,4.6587769027773657e-4,0.029638694962431242,0,0,8.438300051203276,64.73515656544363,HSP90AA1;HSP90AB1;DMTN;TFRC;SNCA
cellular iron ion homeostasis (GO:0006879),4/58,5.672176354997896e-4,0.0344455800467145,0,0,11.557305336832895,86.3881702155822,ALAS2;TFRC;MYC;FTL
response to testosterone (GO:0033574),2/6,6.277332252970674e-4,0.034943816208203415,0,0,76.99612403100775,567.7228576803623,NCOA4;MSN
positive regulation of tau-protein kinase activity (GO:1902949),2/6,6.277332252970674e-4,0.034943816208203415,0,0,76.99612403100775,567.7228576803623,HSP90AA1;HSP90AB1
iron ion homeostasis (GO:0055072),4/61,6.872050899714256e-4,0.035866176673093136,0,0,10.947368421052632,79.72834622857452,ALAS2;TFRC;MYC;FTL
cellular response to unfolded protein (GO:0034620),3/27,7.159781617885379e-4,0.035866176673093136,0,0,19.3798828125,140.3464154268152,HSPA8;OPTN;HSPD1
regulation of autophagy (GO:0010506),7/231,8.315854820084102e-4,0.035866176673093136,0,0,4.95085685483871,35.112350442890765,TP53INP1;PIP4K2A;FOXO3;GAPDH;DCAF12;OPTN;EIF4G2
regulation of hemoglobin biosynthetic process (GO:0046984),2/7,8.75056732408768e-4,0.035866176673093136,0,0,61.5937984496124,433.69559864685533,SLC25A37;EIF2AK1
oxygen transport (GO:0015671),2/7,8.75056732408768e-4,0.035866176673093136,0,0,61.5937984496124,433.69559864685533,MYC;HBA1
response to host defenses (GO:0052200),2/7,8.75056732408768e-4,0.035866176673093136,0,0,61.5937984496124,433.69559864685533,UBB;UBA52
modulation by symbiont of host defense response (GO:0052031),2/7,8.75056732408768e-4,0.035866176673093136,0,0,61.5937984496124,433.69559864685533,UBB;UBA52
aggrephagy (GO:0035973),3/29,8.859160405778993e-4,0.035866176673093136,0,0,17.88731971153846,125.72797356561715,UBB;VIM;UBA52
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),3/29,8.859160405778993e-4,0.035866176673093136,0,0,17.88731971153846,125.72797356561715,UBB;UBA52;HSPD1
positive regulation of apoptotic process (GO:0043065),8/310,0.0010136837895418742,0.03905793458346453,0,0,4.21407419372207,29.052519725182883,BNIP3L;BTG1;ARHGEF12;UBB;FOXO3;UBA52;HSPD1;SNCA
mitochondrion organization (GO:0007005),6/175,0.0010441594389610316,0.03905793458346453,0,0,5.595266272189349,38.40894637998221,BNIP3L;ATP5F1B;FBXO7;BCL2L1;HSPD1;TRAK2
regulation of cellular pH (GO:0030641),3/31,0.0010794591683079197,0.03905793458346453,0,0,16.607979910714285,113.45401233897793,ATP5F1B;CA2;SLC4A1
regulation of cellular response to stress (GO:0080135),5/118,0.001081694296098943,0.03905793458346453,0,0,6.9377721590110975,47.37961868944727,HSPA8;HSP90AA1;NPM1;HSP90AB1;BAG1
protein stabilization (GO:0050821),6/179,0.0011730084345167803,0.041240507066168906,0,0,5.46478612716763,36.87737967703894,HSP90AA1;HSP90AB1;BAG1;AHSP;GAPDH;HSPD1
positive regulation of telomerase activity (GO:0051973),3/34,0.0014166134642850743,0.04852809200730408,0,0,14.998487903225806,98.3823735227885,HSP90AA1;HSP90AB1;MYC
regulation of transmembrane transporter activity (GO:0022898),2/9,0.0014872633947807551,0.04967459738567722,0,0,43.991140642303435,286.41828814216444,PIM1;SNCA
regulation of RNA splicing (GO:0043484),4/76,0.0015665924822287646,0.051047989177015356,0,0,8.66010498687664,55.934339981139296,RBM38;RPS26;HNRNPK;MBNL3
regulation of cellular response to heat (GO:1900034),4/79,0.001807191494753261,0.051522700828700946,0,0,8.31244094488189,52.50122155802467,HSPA8;HSP90AA1;HSP90AB1;BAG1
regulation of erythrocyte differentiation (GO:0045646),3/37,0.001813299340539853,0.051522700828700946,0,0,13.673023897058824,86.312429822796,FAM210B;CDK6;FOXO3
regulation of intracellular pH (GO:0051453),3/37,0.001813299340539853,0.051522700828700946,0,0,13.673023897058824,86.312429822796,ATP5F1B;CA2;SLC4A1
negative regulation of peptidyl-lysine acetylation (GO:2000757),2/10,0.001851114999833567,0.051522700828700946,0,0,38.49031007751938,242.17976540137838,SET;SNCA
regulation of tau-protein kinase activity (GO:1902947),2/10,0.001851114999833567,0.051522700828700946,0,0,38.49031007751938,242.17976540137838,HSP90AA1;HSP90AB1
modification-dependent macromolecule catabolic process (GO:0043632),2/10,0.001851114999833567,0.051522700828700946,0,0,38.49031007751938,242.17976540137838,UBB;UBA52
modulation by symbiont of host process (GO:0044003),2/10,0.001851114999833567,0.051522700828700946,0,0,38.49031007751938,242.17976540137838,UBB;UBA52
lymphocyte proliferation (GO:0046651),3/38,0.0019593672365181792,0.05342274750996505,0,0,13.28169642857143,82.81315294680145,CR2;MSN;HSPD1
regulation of cellular component biogenesis (GO:0044087),3/39,0.002112561422785742,0.05644764121683502,0,0,12.912109375,79.53671017384555,HSPA8;HSP90AA1;MSN
erythrocyte development (GO:0048821),2/11,0.002252786052583026,0.05901416012256711,0,0,34.21188630490956,208.54154935693353,ALAS2;DMTN
protein ubiquitination (GO:0016567),10/525,0.002418235168882444,0.06213004203128741,0,0,3.1058332664687476,18.71176733039851,RNF10;UBE2H;RNF11;UBB;MKRN1;MARCHF8;TRIM58;LNPEP;FBXO7;UBA52
receptor-mediated endocytosis (GO:0006898),5/143,0.002521511375198006,0.06351470696595485,0,0,5.673740510697033,33.945403974844055,HSP90AA1;TFRC;CANX;HBA1;SNCA
mitotic cell cycle phase transition (GO:0044772),6/209,0.002567211209701768,0.06351470696595485,0,0,4.650088669950739,27.737477133263464,HSP90AA1;CDK6;CCNI;MYC;OPTN;GSPT1
negative regulation of cell division (GO:0051782),2/12,0.0026917731636562324,0.06421801690437012,0,0,30.789147286821706,182.19647659489397,MYC;TXNIP
negative regulation of histone acetylation (GO:0035067),2/12,0.0026917731636562324,0.06421801690437012,0,0,30.789147286821706,182.19647659489397,SET;SNCA
positive regulation of programmed cell death (GO:0043068),7/286,0.002810323513977701,0.06585501678339963,0,0,3.9637530350329517,23.284891501965724,BNIP3L;ARHGEF12;UBB;FOXO3;UBA52;HSPD1;SNCA
negative regulation of translation (GO:0017148),4/90,0.00290826795675193,0.06585501678339963,0,0,7.245193188060795,42.313359715344966,NCL;CAPRIN1;GAPDH;CPEB4
"regulation of mRNA splicing, via spliceosome (GO:0048024)",4/90,0.00290826795675193,0.06585501678339963,0,0,7.245193188060795,42.313359715344966,DDX5;HNRNPK;NCL;MBNL3
cellular response to organic cyclic compound (GO:0071407),5/150,0.003098518432642887,0.06899367710018162,0,0,5.39792008757526,31.182873213109954,FAM210B;DMTN;RIOK3;NCOA4;MSN
central nervous system neuron axonogenesis (GO:0021955),2/13,0.003167577825533258,0.06937514712971202,0,0,27.98872445384073,161.06917775087956,HSP90AA1;HSP90AB1
positive regulation of peptidyl-serine phosphorylation (GO:0033138),4/93,0.003273589131088689,0.06976097482840198,0,0,6.999911527912944,40.05257189105276,HSP90AA1;HSP90AB1;TFRC;SNCA
erythrocyte differentiation (GO:0030218),3/46,0.003394059404076443,0.06976097482840198,0,0,10.806322674418604,61.44181799504068,ALAS2;DMTN;AHSP
regulation of telomerase activity (GO:0051972),3/46,0.003394059404076443,0.06976097482840198,0,0,10.806322674418604,61.44181799504068,HSP90AA1;HSP90AB1;MYC
interleukin-12-mediated signaling pathway (GO:0035722),3/46,0.003394059404076443,0.06976097482840198,0,0,10.806322674418604,61.44181799504068,CA1;HNRNPA2B1;MSN
cellular transition metal ion homeostasis (GO:0046916),4/96,0.0036690070796085075,0.0733744434346056,0,0,6.770626497774734,37.968550856976634,ALAS2;TFRC;MYC;FTL
response to chemokine (GO:1990868),2/14,0.003679706369849233,0.0733744434346056,0,0,25.655038759689923,143.79449938483123,WNK1;DOCK8
cellular response to interleukin-12 (GO:0071349),3/48,0.0038305984619632135,0.07525999331151255,0,0,10.325,57.45588094136373,CA1;HNRNPA2B1;MSN
negative regulation of neuron death (GO:1901215),4/98,0.003949905260336944,0.07647932504072692,0,0,6.625900485843525,36.668155259670975,SET;FBXO7;CPEB4;SNCA
organic anion transport (GO:0015711),4/99,0.004095665541728262,0.07663984950581364,0,0,6.555822627434728,36.042772416555685,CA1;CA2;SLC4A1;HBA1
regulation of cytoplasmic translation (GO:2000765),2/15,0.0042276699293122095,0.07663984950581364,0,0,23.680381633870006,129.43943544423092,YBX3;CPEB4
central nervous system neuron development (GO:0021954),2/15,0.0042276699293122095,0.07663984950581364,0,0,23.680381633870006,129.43943544423092,HSP90AA1;HSP90AB1
T cell proliferation (GO:0042098),2/15,0.0042276699293122095,0.07663984950581364,0,0,23.680381633870006,129.43943544423092,DOCK8;MSN
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),4/100,0.004245021604363929,0.07663984950581364,0,0,6.487204724409449,35.433166501749184,HSP90AB1;UBB;LDLRAD4;UBA52
cellular response to chemical stress (GO:0062197),4/101,0.004398014292863928,0.07834329460354944,0,0,6.420001623508401,34.83879452967079,PRDX2;CAT;FOXO3;SNCA
regulation of cell death (GO:0010941),4/102,0.004554684128818833,0.0790267272221034,0,0,6.354170014462478,34.25913731030464,BNIP3L;UBB;HBA1;SNCA
positive regulation of cellular protein metabolic process (GO:0032270),4/102,0.004554684128818833,0.0790267272221034,0,0,6.354170014462478,34.25913731030464,HSP90AA1;NPM1;MSN;VIM
protein polyubiquitination (GO:0000209),7/314,0.004683242486084755,0.07920015141024345,0,0,3.597089418934538,19.293940780574385,UBE2H;UBB;MKRN1;MARCHF8;LNPEP;FBXO7;UBA52
cellular macromolecule biosynthetic process (GO:0034645),7/314,0.004683242486084755,0.07920015141024345,0,0,3.597089418934538,19.293940780574385,RPS26;ALAS2;SET;NAP1L1;PTMA;GSPT1;EIF4G2
negative regulation of histone modification (GO:0031057),2/16,0.004810984392675328,0.07935154504462022,0,0,21.98781838316722,117.34576682279196,SET;SNCA
regulation of monocyte differentiation (GO:0045655),2/16,0.004810984392675328,0.07935154504462022,0,0,21.98781838316722,117.34576682279196,CDK6;MYC
positive regulation of macroautophagy (GO:0016239),3/53,0.0050665604750912314,0.0825478633502669,0,0,9.29015625,49.09934068440332,BNIP3L;PIP4K2A;OPTN
regulation of proteasomal protein catabolic process (GO:0061136),3/54,0.005339216401671557,0.08594208569437592,0,0,9.107536764705882,47.6567924907854,GABARAPL2;HSP90AB1;UBB
regulation of receptor recycling (GO:0001919),2/17,0.005429170370171551,0.08634966207796657,0,0,20.52093023255814,107.03653477551352,OPTN;SNCA
protein targeting to mitochondrion (GO:0006626),3/55,0.005620542132128593,0.08834169751204471,0,0,8.93194110576923,46.27930899762371,HSP90AA1;FBXO7;HSPD1
protein-containing complex disassembly (GO:0032984),3/56,0.00591061040420762,0.09028024672846856,0,0,8.762971698113208,44.96286184716841,GABARAPL2;HSPA8;MYC
mitochondrial transport (GO:0006839),3/56,0.00591061040420762,0.09028024672846856,0,0,8.762971698113208,44.96286184716841,HSP90AA1;FBXO7;BCL2L1
regulation of cellular protein catabolic process (GO:1903362),2/18,0.006081753147875876,0.09028024672846856,0,0,19.237403100775193,98.15812364603615,HSP90AA1;MSN
cellular response to dsRNA (GO:0071359),2/18,0.006081753147875876,0.09028024672846856,0,0,19.237403100775193,98.15812364603615,NPM1;RIOK3
intracellular estrogen receptor signaling pathway (GO:0030520),2/18,0.006081753147875876,0.09028024672846856,0,0,19.237403100775193,98.15812364603615,DDX5;NCOA4
carbohydrate derivative catabolic process (GO:1901136),2/19,0.006768262653070667,0.09610705525272331,0,0,18.10487916096671,90.4431202748417,BPGM;STT3B
endoplasmic reticulum mannose trimming (GO:1904380),2/19,0.006768262653070667,0.09610705525272331,0,0,18.10487916096671,90.4431202748417,UBB;UBA52
positive regulation of cellular protein catabolic process (GO:1903364),2/19,0.006768262653070667,0.09610705525272331,0,0,18.10487916096671,90.4431202748417,HSP90AA1;MSN
response to fatty acid (GO:0070542),2/19,0.006768262653070667,0.09610705525272331,0,0,18.10487916096671,90.4431202748417,SCD;FOXO3
selective autophagy (GO:0061912),3/59,0.006833959767222092,0.09610705525272331,0,0,8.292271205357142,41.34402878478638,UBB;VIM;UBA52
regulation of protein-containing complex assembly (GO:0043254),4/116,0.007156036958898692,0.09913462653644141,0,0,5.555961754780652,27.445334034762343,HSPA8;HSP90AA1;TFRC;RIOK3
protein targeting to lysosome (GO:0006622),2/20,0.00748823341082939,0.09913462653644141,0,0,17.098191214470283,83.68576954910893,HSPA8;NCOA4
protein-DNA complex disassembly (GO:0032986),2/20,0.00748823341082939,0.09913462653644141,0,0,17.098191214470283,83.68576954910893,SET;MYC
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/20,0.00748823341082939,0.09913462653644141,0,0,17.098191214470283,83.68576954910893,HSP90AA1;HSP90AB1
myeloid cell development (GO:0061515),2/20,0.00748823341082939,0.09913462653644141,0,0,17.098191214470283,83.68576954910893,ALAS2;DMTN
positive regulation of DNA biosynthetic process (GO:2000573),3/61,0.007494459042051335,0.09913462653644141,0,0,8.005522629310345,39.1757560978979,HSP90AA1;HSP90AB1;MYC
amyloid fibril formation (GO:1990000),3/63,0.008191462537552803,0.10485951640024278,0,0,7.737890625,37.177955399259325,UBB;UBA52;SNCA
cell cycle G1/S phase transition (GO:0044843),3/63,0.008191462537552803,0.10485951640024278,0,0,7.737890625,37.177955399259325,CDK6;MYC;GSPT1
purinergic nucleotide receptor signaling pathway (GO:0035590),2/21,0.008241204507504112,0.10485951640024278,0,0,16.197470420236638,77.72532357227595,HSP90AB1;TXNIP
error-prone translesion synthesis (GO:0042276),2/21,0.008241204507504112,0.10485951640024278,0,0,16.197470420236638,77.72532357227595,UBB;UBA52
regulation of innate immune response (GO:0045088),3/64,0.008553791031965649,0.10680247494117857,0,0,7.610655737704918,36.23722933435961,HSP90AB1;RIOK3;ERAP1
protein catabolic process (GO:0030163),3/64,0.008553791031965649,0.10680247494117857,0,0,7.610655737704918,36.23722933435961,HSPA8;HSP90AA1;STT3B
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",2/22,0.009026719548951435,0.10864592177837043,0,0,15.386821705426357,72.43448272713856,UBB;UBA52
error-free translesion synthesis (GO:0070987),2/22,0.009026719548951435,0.10864592177837043,0,0,15.386821705426357,72.43448272713856,UBB;UBA52
heme biosynthetic process (GO:0006783),2/22,0.009026719548951435,0.10864592177837043,0,0,15.386821705426357,72.43448272713856,ALAS2;FECH
positive regulation of signal transduction by p53 class mediator (GO:1901798),2/22,0.009026719548951435,0.10864592177837043,0,0,15.386821705426357,72.43448272713856,DDX5;UBB
cellular response to oxidative stress (GO:0034599),4/125,0.009260920462697605,0.11046955123360715,0,0,5.140365718747966,24.066944700441393,PRDX2;CAT;FOXO3;SNCA
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",2/23,0.009844326624428709,0.11338587749467814,0,0,14.653377630121817,67.7112060716613,UBB;UBA52
regulation of necroptotic process (GO:0060544),2/23,0.009844326624428709,0.11338587749467814,0,0,14.653377630121817,67.7112060716613,HSP90AA1;YBX3
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/68,0.010096449268684683,0.11338587749467814,0,0,7.140865384615385,32.81635726479536,UBB;LDLRAD4;UBA52
regulation of translational initiation (GO:0006446),3/68,0.010096449268684683,0.11338587749467814,0,0,7.140865384615385,32.81635726479536,NPM1;EIF4G2;EIF1
regulation of macromolecule metabolic process (GO:0060255),5/200,0.01026400351490263,0.11338587749467814,0,0,4.003663003663004,18.333222542039042,CDK6;HNRNPK;MYC;TRIM58;YBX3
positive regulation of macromolecule biosynthetic process (GO:0010557),4/129,0.01031305428108499,0.11338587749467814,0,0,4.974866141732283,22.756752968108785,SLC25A37;NPM1;MYC;VIM
modification-dependent protein catabolic process (GO:0019941),5/201,0.010471943006103185,0.11338587749467814,0,0,3.9830336896663425,18.15887241785741,UBE2H;RNF11;UBB;FBXO7;UBA52
cellular response to decreased oxygen levels (GO:0036294),3/69,0.010505677769553317,0.11338587749467814,0,0,7.032315340909091,32.03809950030175,BNIP3L;MYC;CPEB4
axon extension (GO:0048675),2/24,0.010693578266713657,0.11338587749467814,0,0,13.98661028893587,63.47280230857581,HSP90AA1;HSP90AB1
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",2/24,0.010693578266713657,0.11338587749467814,0,0,13.98661028893587,63.47280230857581,UBB;UBA52
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/24,0.010693578266713657,0.11338587749467814,0,0,13.98661028893587,63.47280230857581,UBB;UBA52
regulation of monooxygenase activity (GO:0032768),2/24,0.010693578266713657,0.11338587749467814,0,0,13.98661028893587,63.47280230857581,HSP90AA1;SNCA
porphyrin-containing compound biosynthetic process (GO:0006779),2/24,0.010693578266713657,0.11338587749467814,0,0,13.98661028893587,63.47280230857581,ALAS2;FECH
"protein alpha-1,2-demannosylation (GO:0036508)",2/24,0.010693578266713657,0.11338587749467814,0,0,13.98661028893587,63.47280230857581,UBB;UBA52
cellular response to hypoxia (GO:0071456),4/131,0.010866967155824817,0.11431707181245634,0,0,4.896025792051584,22.139963895549293,BNIP3L;UBB;MYC;UBA52
negative regulation of ion transport (GO:0043271),2/25,0.011574031416388306,0.11894543055611367,0,0,13.377822716548703,59.651595927977866,WNK1;SNCA
peptide catabolic process (GO:0043171),2/25,0.011574031416388306,0.11894543055611367,0,0,13.377822716548703,59.651595927977866,ERAP1;LNPEP
positive regulation of T cell migration (GO:2000406),2/25,0.011574031416388306,0.11894543055611367,0,0,13.377822716548703,59.651595927977866,WNK1;DOCK8
negative regulation of protein localization to membrane (GO:1905476),2/26,0.012485247380843015,0.12355770741337975,0,0,12.819767441860465,56.191701327620784,DMTN;BCL2L1
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),2/26,0.012485247380843015,0.12355770741337975,0,0,12.819767441860465,56.191701327620784,GABARAPL2;HSP90AB1
cellular response to drug (GO:0035690),2/26,0.012485247380843015,0.12355770741337975,0,0,12.819767441860465,56.191701327620784,TFRC;MYC
chaperone cofactor-dependent protein refolding (GO:0051085),2/26,0.012485247380843015,0.12355770741337975,0,0,12.819767441860465,56.191701327620784,HSPA8;BAG1
global genome nucleotide-excision repair (GO:0070911),2/26,0.012485247380843015,0.12355770741337975,0,0,12.819767441860465,56.191701327620784,UBB;UBA52
positive regulation of T cell activation (GO:0050870),3/75,0.013162009112510894,0.12632530874839903,0,0,6.4443359375,27.906685719681,TFRC;DOCK8;HSPD1
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),2/27,0.01342679179810828,0.12632530874839903,0,0,12.306356589147287,53.04658921447195,UBB;UBA52
positive regulation of erythrocyte differentiation (GO:0045648),2/27,0.01342679179810828,0.12632530874839903,0,0,12.306356589147287,53.04658921447195,FAM210B;FOXO3
positive regulation of nitric oxide biosynthetic process (GO:0045429),2/27,0.01342679179810828,0.12632530874839903,0,0,12.306356589147287,53.04658921447195,HSP90AA1;HSP90AB1
stress-activated protein kinase signaling cascade (GO:0031098),2/27,0.01342679179810828,0.12632530874839903,0,0,12.306356589147287,53.04658921447195,UBB;UBA52
presynaptic endocytosis (GO:0140238),2/27,0.01342679179810828,0.12632530874839903,0,0,12.306356589147287,53.04658921447195,CANX;SNCA
protein export from nucleus (GO:0006611),2/27,0.01342679179810828,0.12632530874839903,0,0,12.306356589147287,53.04658921447195,STRADB;XPO7
regulation of cell division (GO:0051302),3/76,0.01363853426758903,0.12742015231817444,0,0,6.355736301369863,27.296972765004416,MYC;TXNIP;BCL2L1
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),2/28,0.01439823460379772,0.13175370842927228,0,0,11.832438878950507,50.17722810865632,UBB;UBA52
positive regulation of fibroblast proliferation (GO:0048146),2/28,0.01439823460379772,0.13175370842927228,0,0,11.832438878950507,50.17722810865632,CDK6;MYC
positive regulation of nitric oxide metabolic process (GO:1904407),2/28,0.01439823460379772,0.13175370842927228,0,0,11.832438878950507,50.17722810865632,HSP90AA1;HSP90AB1
protein-DNA complex assembly (GO:0065004),4/143,0.01459447159857129,0.13264091194347782,0,0,4.4706282218319835,18.897848348197517,NPM1;UBB;NAP1L1;UBA52
MAPK cascade (GO:0000165),6/303,0.014876116264592086,0.13359262582376946,0,0,3.1631515151515153,13.310536158443833,UBB;MYC;UBA52;SPTAN1;SPTB;BCL2L1
negative regulation of cell migration (GO:0030336),4/144,0.014937207890673791,0.13359262582376946,0,0,4.438470191226097,18.658884858722374,TP53INP1;LDLRAD4;ADIPOR1;FOXO3
regulation of ion transport (GO:0043269),3/79,0.015126616212725099,0.13359262582376946,0,0,6.1039268092105265,25.58338491796081,CA2;WNK1;SNCA
negative regulation of epithelial to mesenchymal transition (GO:0010719),2/29,0.015399149982680011,0.13359262582376946,0,0,11.393626184323859,47.550649067773186,LDLRAD4;ADIPOR1
negative regulation of myeloid leukocyte differentiation (GO:0002762),2/29,0.015399149982680011,0.13359262582376946,0,0,11.393626184323859,47.550649067773186,CDK6;MYC
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.015399149982680011,0.13359262582376946,0,0,11.393626184323859,47.550649067773186,UBB;UBA52
telomere maintenance via telomerase (GO:0007004),2/29,0.015399149982680011,0.13359262582376946,0,0,11.393626184323859,47.550649067773186,HSP90AA1;HSP90AB1
negative regulation of cell cycle (GO:0045786),3/80,0.015642221689938604,0.13482585921134177,0,0,6.02435064935065,25.04793369243798,BTG1;CDK6;HECA
positive regulation of transferase activity (GO:0051347),4/148,0.016358911870244273,0.1380459084349891,0,0,4.314304461942257,17.744658586050043,HSP90AA1;HSP90AB1;MYC;HNRNPA2B1
RNA-dependent DNA biosynthetic process (GO:0006278),2/30,0.016429116348176096,0.1380459084349891,0,0,10.986157253599114,45.13882574929996,HSP90AA1;HSP90AB1
ion homeostasis (GO:0050801),2/30,0.016429116348176096,0.1380459084349891,0,0,10.986157253599114,45.13882574929996,WNK1;SLC4A1
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),2/30,0.016429116348176096,0.1380459084349891,0,0,10.986157253599114,45.13882574929996,UBB;UBA52
'de novo' posttranslational protein folding (GO:0051084),2/31,0.01748771629334441,0.14421968498708723,0,0,10.606789628441593,42.91779222718881,HSPA8;BAG1
organelle transport along microtubule (GO:0072384),2/31,0.01748771629334441,0.14421968498708723,0,0,10.606789628441593,42.91779222718881,UBB;TRAK2
MyD88-independent toll-like receptor signaling pathway (GO:0002756),2/31,0.01748771629334441,0.14421968498708723,0,0,10.606789628441593,42.91779222718881,UBB;UBA52
negative regulation of protein phosphorylation (GO:0001933),4/152,0.017862867400742753,0.14640975979995288,0,0,4.196850393700787,16.892453640679353,DMTN;FKBP8;LDLRAD4;SNCA
G1/S transition of mitotic cell cycle (GO:0000082),3/85,0.01836791326130779,0.14740346661608758,0,0,5.655583079268292,22.606213798565868,CDK6;MYC;GSPT1
positive regulation of protein catabolic process (GO:0045732),3/85,0.01836791326130779,0.14740346661608758,0,0,5.655583079268292,22.606213798565868,HSP90AA1;MSN;OAZ1
B cell proliferation (GO:0042100),2/32,0.01857453656031179,0.14740346661608758,0,0,10.252713178294574,40.866941922973595,CR2;HSPD1
cellular response to topologically incorrect protein (GO:0035967),2/32,0.01857453656031179,0.14740346661608758,0,0,10.252713178294574,40.866941922973595,HSPA8;OPTN
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),2/32,0.01857453656031179,0.14740346661608758,0,0,10.252713178294574,40.866941922973595,MSN;ANK1
positive regulation of protein kinase activity (GO:0045860),4/154,0.01864609719919072,0.14740346661608758,0,0,4.140472440944882,16.48785157562545,HSP90AA1;HSP90AB1;STRADB;SNCA
negative regulation of cellular amide metabolic process (GO:0034249),3/86,0.018942683473400876,0.14880064985265418,0,0,5.587161144578313,22.1605668690796,NCL;CAPRIN1;GAPDH
positive regulation of NF-kappaB transcription factor activity (GO:0051092),4/155,0.01904559215928433,0.14880064985265418,0,0,4.1128435104552326,16.29064241840546,NPM1;TFRC;UBB;UBA52
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),2/33,0.01968916800271705,0.15031273400931416,0,0,9.921480370092523,38.968465918850896,ERAP1;CANX
apoptotic mitochondrial changes (GO:0008637),2/33,0.01968916800271705,0.15031273400931416,0,0,9.921480370092523,38.968465918850896,HSPD1;BCL2L1
regulation of histone acetylation (GO:0035065),2/33,0.01968916800271705,0.15031273400931416,0,0,9.921480370092523,38.968465918850896,SET;SNCA
neuron projection extension (GO:1990138),2/33,0.01968916800271705,0.15031273400931416,0,0,9.921480370092523,38.968465918850896,HSP90AA1;HSP90AB1
cellular response to starvation (GO:0009267),4/158,0.020275813792638795,0.15391185924412176,0,0,4.032109622660804,15.718479962466226,GABARAPL2;HSPA8;FOXO3;CPEB4
negative regulation of mitochondrion organization (GO:0010823),2/34,0.02083120555154078,0.1554776012114999,0,0,9.6109496124031,37.20689950562277,TFRC;BCL2L1
regulation of transmembrane transport (GO:0034762),2/34,0.02083120555154078,0.1554776012114999,0,0,9.6109496124031,37.20689950562277,PIM1;SNCA
synaptic vesicle recycling (GO:0036465),2/34,0.02083120555154078,0.1554776012114999,0,0,9.6109496124031,37.20689950562277,CANX;SNCA
axonogenesis (GO:0007409),5/240,0.020988603053416773,0.15578207599647118,0,0,3.315433975008443,12.810093228659913,HSP90AA1;HSP90AB1;BSG;SPTAN1;SPTB
toll-like receptor signaling pathway (GO:0002224),3/91,0.021965205650225576,0.16149632729509047,0,0,5.268377130681818,20.116221422508488,UBB;UBA52;HSPD1
cellular response to virus (GO:0098586),2/35,0.02200024817942101,0.16149632729509047,0,0,9.31923890063425,35.56875350845458,HSP90AA1;RIOK3
cellular response to heat (GO:0034605),2/36,0.023195898865407842,0.1643044923777179,0,0,9.04468764249886,34.04221254646382,HSP90AA1;HSP90AB1
positive regulation of interferon-beta production (GO:0032728),2/36,0.023195898865407842,0.1643044923777179,0,0,9.04468764249886,34.04221254646382,HSP90AA1;RIOK3
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/36,0.023195898865407842,0.1643044923777179,0,0,9.04468764249886,34.04221254646382,DDX5;HIPK1
telomere maintenance via telomere lengthening (GO:0010833),2/36,0.023195898865407842,0.1643044923777179,0,0,9.04468764249886,34.04221254646382,HSP90AA1;HSP90AB1
positive regulation of T cell mediated immunity (GO:0002711),2/36,0.023195898865407842,0.1643044923777179,0,0,9.04468764249886,34.04221254646382,CD1E;HSPD1
mitochondrion disassembly (GO:0061726),2/36,0.023195898865407842,0.1643044923777179,0,0,9.04468764249886,34.04221254646382,GABARAPL2;FBXO7
cytoplasmic translation (GO:0002181),3/93,0.023243674445650214,0.1643044923777179,0,0,5.15078125,19.3758084372285,RPS26;UBA52;GSPT1
negative regulation of cellular protein metabolic process (GO:0032269),3/94,0.02389779704452073,0.1662888377681234,0,0,5.0939217032967035,19.020545719176344,NCL;CAPRIN1;GAPDH
nucleosome organization (GO:0034728),3/94,0.02389779704452073,0.1662888377681234,0,0,5.0939217032967035,19.020545719176344,NPM1;SET;NAP1L1
hemopoiesis (GO:0030097),3/94,0.02389779704452073,0.1662888377681234,0,0,5.0939217032967035,19.020545719176344,GLRX5;AHSP;HIPK1
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",2/37,0.02441776456216778,0.16729299207721104,0,0,8.785825027685492,32.616886534730405,UBB;UBA52
regulation of transport (GO:0051049),2/37,0.02441776456216778,0.16729299207721104,0,0,8.785825027685492,32.616886534730405,EPB41;SNCA
positive regulation of myeloid cell differentiation (GO:0045639),2/37,0.02441776456216778,0.16729299207721104,0,0,8.785825027685492,32.616886534730405,FAM210B;FOXO3
cellular protein-containing complex assembly (GO:0034622),4/168,0.024725302675461778,0.16853573660416804,0,0,3.7843287881697716,14.001744649561246,HSP90AA1;HSP90AB1;HSPD1;SNCA
negative regulation of proteasomal protein catabolic process (GO:1901799),2/38,0.025665456157879487,0.1731770173077121,0,0,8.541343669250645,31.283604839394577,GABARAPL2;HSP90AB1
synaptic vesicle endocytosis (GO:0048488),2/38,0.025665456157879487,0.1731770173077121,0,0,8.541343669250645,31.283604839394577,CANX;SNCA
positive regulation of cold-induced thermogenesis (GO:0120162),3/97,0.02591968283565627,0.17401354908762198,0,0,4.9306017287234045,18.010268500373787,SCD;GNAS;ADIPOR1
nuclear-transcribed mRNA catabolic process (GO:0000956),4/171,0.026166271875112626,0.17479069612575235,0,0,3.715781036352492,13.53764571076734,RPS26;DDX5;UBA52;GSPT1
regulation of neuron apoptotic process (GO:0043523),3/98,0.02661346655529498,0.175560752012433,0,0,4.878453947368421,17.690922588243357,SET;FOXO3;CPEB4
positive regulation of defense response (GO:0031349),3/98,0.02661346655529498,0.175560752012433,0,0,4.878453947368421,17.690922588243357,RIOK3;OPTN;SNCA
regulation of exit from mitosis (GO:0007096),2/39,0.026938588445021533,0.175560752012433,0,0,8.310077519379846,30.034244821919533,UBB;UBA52
cellular response to ketone (GO:1901655),2/39,0.026938588445021533,0.175560752012433,0,0,8.310077519379846,30.034244821919533,NCOA4;MSN
"nucleotide-excision repair, DNA incision (GO:0033683)",2/39,0.026938588445021533,0.175560752012433,0,0,8.310077519379846,30.034244821919533,UBB;UBA52
response to UV (GO:0009411),3/99,0.027317149107389912,0.17716364663821807,0,0,4.827392578125,17.37977475951745,NPM1;MYC;CAT
positive regulation of translation (GO:0045727),3/100,0.028030721333160258,0.17878833271543604,0,0,4.777384020618556,17.076540281059767,NPM1;VIM;YBX3
autophagy of mitochondrion (GO:0000422),2/40,0.02823678009203369,0.17878833271543604,0,0,8.090983272133823,28.861588287818005,GABARAPL2;FBXO7
regulation of nitric oxide biosynthetic process (GO:0045428),2/40,0.02823678009203369,0.17878833271543604,0,0,8.090983272133823,28.861588287818005,HSP90AA1;HSP90AB1
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/40,0.02823678009203369,0.17878833271543604,0,0,8.090983272133823,28.861588287818005,UBB;BCL2L1
ribosomal small subunit biogenesis (GO:0042274),2/40,0.02823678009203369,0.17878833271543604,0,0,8.090983272133823,28.861588287818005,NPM1;RIOK3
regulation of mitochondrial membrane potential (GO:0051881),2/41,0.02955965359042763,0.1799523730719481,0,0,7.883124627310674,27.75920071689616,UBB;BCL2L1
JNK cascade (GO:0007254),2/41,0.02955965359042763,0.1799523730719481,0,0,7.883124627310674,27.75920071689616,UBB;UBA52
gene expression (GO:0010467),6/356,0.029910445031187508,0.1799523730719481,0,0,2.6768914285714285,9.39467769437093,RPS26;HNRNPK;HNRNPA2B1;PTMA;GSPT1;HSPD1
translesion synthesis (GO:0019985),2/42,0.03090683524836144,0.1799523730719481,0,0,7.685658914728682,26.72132916997424,UBB;UBA52
cellular response to glucose starvation (GO:0042149),2/43,0.03227795514099813,0.1799523730719481,0,0,7.497825675931178,25.74281562781207,FOXO3;CPEB4
DNA synthesis involved in DNA repair (GO:0000731),2/43,0.03227795514099813,0.1799523730719481,0,0,7.497825675931178,25.74281562781207,UBB;UBA52
signal release from synapse (GO:0099643),2/43,0.03227795514099813,0.1799523730719481,0,0,7.497825675931178,25.74281562781207,HSPA8;SNCA
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,CD1E
"antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)",1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,CD1E
"antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)",1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,CD1E
carbon dioxide transport (GO:0015670),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,CA2
cellular response to vitamin D (GO:0071305),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,PIM1
peptidyl-cysteine S-nitrosylation (GO:0018119),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,GAPDH
dopamine biosynthetic process (GO:0042416),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,SNCA
regulation of protein import (GO:1904589),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,HSPA8
PML body organization (GO:0030578),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,SERBP1
endothelial cell apoptotic process (GO:0072577),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,HIPK1
regulation of protein monoubiquitination (GO:1902525),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,UBB
regulation of ribonuclease activity (GO:0060700),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,NPM1
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,PIM1
regulation of synaptic vesicle recycling (GO:1903421),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,SNCA
glutamate catabolic process (GO:0006538),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,GLUL
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,UBB
positive regulation of low-density lipoprotein receptor activity (GO:1905599),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,HNRNPK
rRNA transport (GO:0051029),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,NPM1
intracellular sequestering of iron ion (GO:0006880),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,FTL
positive regulation of protein localization to cell cortex (GO:1904778),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,EPB41
positive regulation of protein monoubiquitination (GO:1902527),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,UBB
protein K29-linked deubiquitination (GO:0035523),1/5,0.032326773605739184,0.1799523730719481,0,0,38.20192307692308,131.10363216765762,YOD1
chromosome organization (GO:0051276),3/106,0.03251917009995614,0.180272245865317,0,0,4.497724514563107,15.408869170777981,UBB;MYC;UBA52
neurogenesis (GO:0022008),2/44,0.03367264707600145,0.18361900609607318,0,0,7.318936877076412,24.81902310880993,CDK6;TRAK2
neurotransmitter secretion (GO:0007269),2/44,0.03367264707600145,0.18361900609607318,0,0,7.318936877076412,24.81902310880993,HSPA8;SNCA
intracellular steroid hormone receptor signaling pathway (GO:0030518),2/44,0.03367264707600145,0.18361900609607318,0,0,7.318936877076412,24.81902310880993,DDX5;NCOA4
mRNA stabilization (GO:0048255),2/44,0.03367264707600145,0.18361900609607318,0,0,7.318936877076412,24.81902310880993,YBX3;TENT5C
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/108,0.034093825756352066,0.18371105473039842,0,0,4.411607142857143,14.905227830613795,UBB;LDLRAD4;UBA52
regulation of protein ubiquitination (GO:0031396),3/109,0.03489579380015496,0.18371105473039842,0,0,4.369767099056604,14.662268362885138,HSP90AA1;HSP90AB1;UBB
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),2/45,0.03509054856415484,0.18371105473039842,0,0,7.148368487470705,23.945772434655535,DDX5;FOXO3
regulation of cellular protein localization (GO:1903827),2/46,0.03653130080252294,0.18371105473039842,0,0,6.985553206483439,23.119287904453852,HSP90AA1;HSP90AB1
regulation of fibroblast proliferation (GO:0048145),2/46,0.03653130080252294,0.18371105473039842,0,0,6.985553206483439,23.119287904453852,CDK6;MYC
positive regulation of organelle assembly (GO:1902117),2/46,0.03653130080252294,0.18371105473039842,0,0,6.985553206483439,23.119287904453852,G3BP1;PIP4K2A
postreplication repair (GO:0006301),2/46,0.03653130080252294,0.18371105473039842,0,0,6.985553206483439,23.119287904453852,UBB;UBA52
regulation of protein localization to nucleus (GO:1900180),2/47,0.03799454861406044,0.18371105473039842,0,0,6.829974160206718,22.33615046549707,TFRC;GLUL
positive regulation of neuron death (GO:1901216),2/47,0.03799454861406044,0.18371105473039842,0,0,6.829974160206718,22.33615046549707,FOXO3;SNCA
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",3/113,0.038200772814556486,0.18371105473039842,0,0,4.2100142045454545,13.745273409614203,RPS26;UBA52;GSPT1
positive regulation of metabolic process (GO:0009893),3/113,0.038200772814556486,0.18371105473039842,0,0,4.2100142045454545,13.745273409614203,SCD;GNAS;ADIPOR1
protein-DNA complex subunit organization (GO:0071824),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,MYC
adiponectin-activated signaling pathway (GO:0033211),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,ADIPOR1
astrocyte development (GO:0014002),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,CDK6
negative regulation of glial cell proliferation (GO:0060253),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,RNF10
axo-dendritic transport (GO:0008088),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,HSPA8
regulation of digestive system process (GO:0044058),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,EPB41
cellular hyperosmotic response (GO:0071474),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,YBX3
negative regulation of protein targeting to membrane (GO:0090315),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,DMTN
negative regulation of transporter activity (GO:0032410),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,SNCA
oxygen homeostasis (GO:0032364),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,ALAS2
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,UBB
regulation of SNARE complex assembly (GO:0035542),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,SNCA
positive regulation of hemoglobin biosynthetic process (GO:0046985),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,SLC25A37
positive regulation of immune response to tumor cell (GO:0002839),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,HSPD1
positive regulation of kidney development (GO:0090184),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,MYC
macromolecule biosynthetic process (GO:0009059),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,EIF4G2
melanosome assembly (GO:1903232),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,HPS1
positive regulation of T cell mediated immune response to tumor cell (GO:0002842),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,HSPD1
mitochondrial protein catabolic process (GO:0035694),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,BNIP3L
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),1/6,0.03866659935826289,0.18371105473039842,0,0,30.56,99.4049298240761,ITM2A
regulation of programmed cell death (GO:0043067),4/194,0.0388775153989619,0.18371105473039842,0,0,3.262163282221301,10.59335072201175,BNIP3L;PRDX2;HSP90AA1;TP53INP1
negative regulation of cell motility (GO:2000146),3/114,0.0390511781129319,0.18371105473039842,0,0,4.171875,13.528899319160576,TP53INP1;LDLRAD4;FOXO3
response to lipid (GO:0033993),3/114,0.0390511781129319,0.18371105473039842,0,0,4.171875,13.528899319160576,SCD;FOXO3;SNCA
neutrophil degranulation (GO:0043312),7/481,0.03913890487972095,0.18371105473039842,0,0,2.309871376071866,7.485457642380959,HSPA8;HSP90AA1;HSP90AB1;CAT;STOM;SPTAN1;FTL
negative regulation of mitotic cell cycle (GO:0045930),2/48,0.039479940438423795,0.18371105473039842,0,0,6.681159420289855,21.59325719109003,BTG1;HECA
establishment of protein localization to mitochondrion (GO:0072655),2/48,0.039479940438423795,0.18371105473039842,0,0,6.681159420289855,21.59325719109003,FBXO7;HSPD1
positive regulation of endocytosis (GO:0045807),2/48,0.039479940438423795,0.18371105473039842,0,0,6.681159420289855,21.59325719109003,HNRNPK;SNCA
positive regulation of gene expression (GO:0010628),7/482,0.03950732866596232,0.18371105473039842,0,0,2.3048896434634973,7.447718657183468,DDX5;NPM1;TFRC;MYC;MSN;VIM;GAPDH
neutrophil activation involved in immune response (GO:0002283),7/485,0.04062625987214667,0.18371105473039842,0,0,2.2900695100553383,7.335872699242456,HSPA8;HSP90AA1;HSP90AB1;CAT;STOM;SPTAN1;FTL
receptor internalization (GO:0031623),2/49,0.04098712829646158,0.18371105473039842,0,0,6.538677222497114,20.887786115308213,TFRC;SNCA
regulation of cellular localization (GO:0060341),2/49,0.04098712829646158,0.18371105473039842,0,0,6.538677222497114,20.887786115308213,HSP90AA1;HSP90AB1
regulation of interferon-beta production (GO:0032648),2/49,0.04098712829646158,0.18371105473039842,0,0,6.538677222497114,20.887786115308213,HSP90AA1;RIOK3
response to hydrogen peroxide (GO:0042542),2/49,0.04098712829646158,0.18371105473039842,0,0,6.538677222497114,20.887786115308213,CAT;HBA1
neutrophil mediated immunity (GO:0002446),7/488,0.0417657668788701,0.18371105473039842,0,0,2.2754342431761785,7.226047033502391,HSPA8;HSP90AA1;HSP90AB1;CAT;STOM;SPTAN1;FTL
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/50,0.04251576774636915,0.18371105473039842,0,0,6.4021317829457365,20.217165618082923,DMTN;CAPRIN1
positive regulation of protein-containing complex assembly (GO:0031334),3/118,0.04254867157147998,0.18371105473039842,0,0,4.025951086956522,12.710356928519314,HSP90AA1;TFRC;SNCA
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),3/119,0.04344687305653342,0.18371105473039842,0,0,3.9910425646551726,12.516773129755968,MYC;HSPD1;SNCA
regulation of epithelial cell migration (GO:0010632),2/51,0.044065517866388126,0.18371105473039842,0,0,6.271159626641354,19.579047687257045,ADIPOR1;GLUL
DNA duplex unwinding (GO:0032508),2/51,0.044065517866388126,0.18371105473039842,0,0,6.271159626641354,19.579047687257045,UBB;UBA52
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/51,0.044065517866388126,0.18371105473039842,0,0,6.271159626641354,19.579047687257045,HIPK1;BCL2L1
cytoskeleton organization (GO:0007010),3/120,0.0443545467089488,0.18371105473039842,0,0,3.956730769230769,12.327353205026585,DMTN;MICAL2;ANK1
macroautophagy (GO:0016236),3/120,0.0443545467089488,0.18371105473039842,0,0,3.956730769230769,12.327353205026585,GABARAPL2;PIP4K2A;YOD1
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,GNAS
angiotensin-activated signaling pathway (GO:0038166),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,CA2
negative regulation of cytoplasmic translation (GO:2000766),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,CPEB4
astrocyte differentiation (GO:0048708),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,CDK6
cellular ion homeostasis (GO:0006873),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,SLC4A1
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,NPM1
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,MYC
regulation of inositol phosphate biosynthetic process (GO:0010919),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,SNCA
"complement activation, alternative pathway (GO:0006957)",1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,CR2
regulation of MDA-5 signaling pathway (GO:0039533),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,RIOK3
definitive hemopoiesis (GO:0060216),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,HIPK1
regulation of T cell mediated immune response to tumor cell (GO:0002840),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,HSPD1
G-quadruplex DNA unwinding (GO:0044806),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,HNRNPA2B1
gas homeostasis (GO:0033483),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,ALAS2
positive regulation of cytoplasmic translation (GO:2000767),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,YBX3
regulation of transforming growth factor beta activation (GO:1901388),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,HSP90AB1
gland morphogenesis (GO:0022612),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,MSN
glandular epithelial cell development (GO:0002068),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,CDK6
positive regulation of fibroblast apoptotic process (GO:2000271),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,BTG1
positive regulation of integrin-mediated signaling pathway (GO:2001046),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,DMTN
hyperosmotic response (GO:0006972),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,YBX3
ribosomal large subunit export from nucleus (GO:0000055),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,NPM1
ribosomal small subunit export from nucleus (GO:0000056),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,NPM1
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,NPM1
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,OPTN
positive regulation of potassium ion import across plasma membrane (GO:1903288),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,WNK1
"synaptic transmission, dopaminergic (GO:0001963)",1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,SNCA
type B pancreatic cell development (GO:0003323),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,CDK6
positive regulation of vesicle fusion (GO:0031340),1/7,0.044965205761108,0.18371105473039842,0,0,25.465384615384615,78.99021819196878,SNCA
regulation of cell cycle (GO:0051726),5/296,0.045431444316023084,0.1841986437153434,0,0,2.669775814105711,8.253747574198595,CDK6;HSP90AB1;MYC;TP53INP1;EIF4G2
negative regulation of protein metabolic process (GO:0051248),2/52,0.04563604121989421,0.1841986437153434,0,0,6.145426356589147,18.971284506471022,HSP90AB1;EIF2AK1
negative regulation of protein-containing complex assembly (GO:0031333),2/52,0.04563604121989421,0.1841986437153434,0,0,6.145426356589147,18.971284506471022,RIOK3;LDLRAD4
myeloid cell differentiation (GO:0030099),2/52,0.04563604121989421,0.1841986437153434,0,0,6.145426356589147,18.971284506471022,ALAS2;AHSP
defense response to symbiont (GO:0140546),3/124,0.04807932946906969,0.18545728655311716,0,0,3.825154958677686,11.60897401093307,BNIP3L;G3BP1;BCL2L1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",2/54,0.0488380751277771,0.18545728655311716,0,0,5.908467501490757,17.839111211552154,DDX5;MBNL3
regulation of cyclin-dependent protein kinase activity (GO:1904029),2/54,0.0488380751277771,0.18545728655311716,0,0,5.908467501490757,17.839111211552154,HSP90AB1;CCNI
pyruvate metabolic process (GO:0006090),2/55,0.05046892795335374,0.18545728655311716,0,0,5.796694456633026,17.311233370516245,BSG;GAPDH
interstrand cross-link repair (GO:0036297),2/55,0.05046892795335374,0.18545728655311716,0,0,5.796694456633026,17.311233370516245,UBB;UBA52
positive regulation of response to DNA damage stimulus (GO:2001022),2/55,0.05046892795335374,0.18545728655311716,0,0,5.796694456633026,17.311233370516245,DDX5;MYC
actin filament reorganization (GO:0090527),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,DMTN
"negative regulation of complement activation, classical pathway (GO:0045959)",1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,CR2
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,ERAP1
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,LNPEP
regulation of anion transport (GO:0044070),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,CA2
autophagosome-lysosome fusion (GO:0061909),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,PIP4K2A
negative regulation of lipid kinase activity (GO:0090219),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,PIP4K2A
negative regulation of mitochondrial fusion (GO:0010637),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,TFRC
regulation of chaperone-mediated autophagy (GO:1904714),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,SNCA
negative regulation of monooxygenase activity (GO:0032769),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,SNCA
negative regulation of nitrogen compound metabolic process (GO:0051172),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,HSP90AB1
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,SNCA
regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,NPM1
cellular response to angiotensin (GO:1904385),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,CA2
cellular response to epinephrine stimulus (GO:0071872),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,SNCA
negative regulation of sodium ion transport (GO:0010766),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,WNK1
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,UBB
regulation of oxidative stress-induced neuron death (GO:1903203),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,FBXO7
dopamine uptake (GO:0090494),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,SNCA
regulation of potassium ion import (GO:1903286),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,WNK1
regulation of protein localization to cell cortex (GO:1904776),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,EPB41
regulation of protein localization to early endosome (GO:1902965),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,MSN
regulation of protein localization to nucleolus (GO:1904749),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,GLUL
regulation of translational termination (GO:0006449),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,GSPT1
positive regulation of early endosome to late endosome transport (GO:2000643),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,MSN
positive regulation of fibroblast migration (GO:0010763),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,DMTN
response to epinephrine (GO:0071871),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,SNCA
positive regulation of homotypic cell-cell adhesion (GO:0034112),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,DMTN
immunological synapse formation (GO:0001771),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,MSN
positive regulation of protein localization to early endosome (GO:1902966),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,MSN
positive regulation of protein localization to endosome (GO:1905668),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,MSN
negative regulation by symbiont of host apoptotic process (GO:0033668),1/8,0.05122285833690137,0.18545728655311716,0,0,21.826373626373627,64.85858386485305,BCL2L1
autophagosome organization (GO:1905037),2/56,0.05211923851701966,0.1881927098884818,0,0,5.689061154177433,16.806744711469648,GABARAPL2;TP53INP1
protein modification by small protein conjugation (GO:0032446),6/409,0.052569557518398764,0.18930708583444947,0,0,2.318531017369727,6.829506886551397,UBE2H;UBB;MKRN1;TRIM58;FBXO7;UBA52
regulation of primary metabolic process (GO:0080090),3/130,0.053945021673326723,0.19089452969962623,0,0,3.6433316929133857,10.637762963503466,SCD;ADIPOR1;OAZ1
receptor metabolic process (GO:0043112),2/58,0.05547695427659432,0.19089452969962623,0,0,5.485326688815061,15.862399605903178,TFRC;SNCA
autophagosome assembly (GO:0000045),2/58,0.05547695427659432,0.19089452969962623,0,0,5.485326688815061,15.862399605903178,GABARAPL2;TP53INP1
regulation of calcium ion transport (GO:0051924),2/58,0.05547695427659432,0.19089452969962623,0,0,5.485326688815061,15.862399605903178,EPB41;SARAF
nucleosome assembly (GO:0006334),2/58,0.05547695427659432,0.19089452969962623,0,0,5.485326688815061,15.862399605903178,NPM1;NAP1L1
cellular response to lipid (GO:0071396),4/219,0.05607327482174735,0.19089452969962623,0,0,2.879179637429042,8.2951928347546815,FAM210B;NCOA4;MSN;VIM
defense response to virus (GO:0051607),3/133,0.05700105577650374,0.19089452969962623,0,0,3.5587139423076923,10.194596189761514,BNIP3L;G3BP1;BCL2L1
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),3/133,0.05700105577650374,0.19089452969962623,0,0,3.5587139423076923,10.194596189761514,DDX5;UBB;UBA52
negative regulation of autophagy (GO:0010507),2/59,0.05718372844200178,0.19089452969962623,0,0,5.388820889432885,15.420034932718023,EIF4G2;SNCA
response to reactive oxygen species (GO:0000302),2/59,0.05718372844200178,0.19089452969962623,0,0,5.388820889432885,15.420034932718023,CAT;HBA1
negative regulation of exocytosis (GO:0045920),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,SNCA
negative regulation of glycoprotein biosynthetic process (GO:0010561),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,ITM2A
negative regulation of necroptotic process (GO:0060546),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,YBX3
"regulation of complement activation, classical pathway (GO:0030450)",1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,CR2
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,LDLRAD4
regulation of endothelial cell differentiation (GO:0045601),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,BTG1
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,YOD1
regulation of fibroblast apoptotic process (GO:2000269),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,BTG1
cellular response to muramyl dipeptide (GO:0071225),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,VIM
one-carbon compound transport (GO:0019755),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,CA2
epithelial cell apoptotic process (GO:1904019),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,HIPK1
positive regulation of autophagosome assembly (GO:2000786),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,PIP4K2A
positive regulation of autophagy of mitochondrion (GO:1903599),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,FBXO7
regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,DDX5
positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,SNCA
response to magnesium ion (GO:0032026),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,SNCA
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,BNIP3L
maintenance of apical/basal cell polarity (GO:0035090),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,ANK1
maintenance of epithelial cell apical/basal polarity (GO:0045199),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,ANK1
type B pancreatic cell differentiation (GO:0003309),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,CDK6
unsaturated fatty acid biosynthetic process (GO:0006636),1/9,0.057439821062312685,0.19089452969962623,0,0,19.097115384615385,54.560792270090865,SCD
organelle organization (GO:0006996),6/420,0.05830384657291739,0.192288352927948,0,0,2.2556521739130435,6.41076019109281,ATP5F1B;DMTN;MYC;MICAL2;ANK1;OPTN
cellular response to chemokine (GO:1990869),2/60,0.05890869820164627,0.192288352927948,0,0,5.2956428762363,14.99602420823152,WNK1;DOCK8
peptidyl-threonine phosphorylation (GO:0018107),2/60,0.05890869820164627,0.192288352927948,0,0,5.2956428762363,14.99602420823152,WNK1;HIPK1
ribonucleoprotein complex biogenesis (GO:0022613),2/60,0.05890869820164627,0.192288352927948,0,0,5.2956428762363,14.99602420823152,NPM1;GLUL
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),4/224,0.059933003112760584,0.192288352927948,0,0,2.813027916964925,7.917345711691877,TFRC;RIOK3;GAPDH;OPTN
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),5/321,0.060233586543794355,0.192288352927948,0,0,2.4554199316857543,6.898564091745567,UBB;YOD1;STT3B;UBA52;DCAF12
pattern recognition receptor signaling pathway (GO:0002221),2/61,0.06065155614565862,0.192288352927948,0,0,5.205623439758245,14.589332236245617,UBB;UBA52
organelle assembly (GO:0070925),6/425,0.06103007282364151,0.192288352927948,0,0,2.228162291169451,6.230807494466204,GABARAPL2;NPM1;G3BP1;HPS1;TP53INP1;SEPTIN6
I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/62,0.06241199804073526,0.192288352927948,0,0,5.118604651162791,14.19899776394465,UBB;UBA52
stress-activated MAPK cascade (GO:0051403),2/62,0.06241199804073526,0.192288352927948,0,0,5.118604651162791,14.19899776394465,UBB;UBA52
regulation of cellular component organization (GO:0051128),3/139,0.06335411183596336,0.192288352927948,0,0,3.400677849264706,9.382522786705474,HSPA8;HSP90AA1;TFRC
positive regulation of response to external stimulus (GO:0032103),3/139,0.06335411183596336,0.192288352927948,0,0,3.400677849264706,9.382522786705474,RIOK3;OPTN;SNCA
negative regulation of cell adhesion mediated by integrin (GO:0033629),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,WNK1
negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,WNK1
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,CR2
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,WNK1
regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,WNK1
regulation of DNA methylation (GO:0044030),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,MYC
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,YOD1
cellular response to oxygen levels (GO:0071453),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,CPEB4
negative regulation of transforming growth factor beta production (GO:0071635),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,HSP90AB1
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,RIOK3
regulation of low-density lipoprotein particle clearance (GO:0010988),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,HNRNPK
nucleic acid transport (GO:0050657),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,HNRNPA2B1
defense response to tumor cell (GO:0002357),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,PRDX2
regulation of neutrophil migration (GO:1902622),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,MPP1
regulation of store-operated calcium entry (GO:2001256),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,SARAF
positive regulation of coagulation (GO:0050820),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,DMTN
positive regulation of dendritic spine morphogenesis (GO:0061003),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,CAPRIN1
removal of superoxide radicals (GO:0019430),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,PRDX2
positive regulation of hemostasis (GO:1900048),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,DMTN
positive regulation of mesenchymal cell proliferation (GO:0002053),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,MYC
ionotropic glutamate receptor signaling pathway (GO:0035235),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,CPEB4
iron ion transmembrane transport (GO:0034755),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,SLC25A37
SNARE complex assembly (GO:0035493),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,SNCA
positive regulation of receptor recycling (GO:0001921),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,SNCA
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,NCL
UV protection (GO:0009650),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,CAT
primary miRNA processing (GO:0031053),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,HNRNPA2B1
protein K11-linked deubiquitination (GO:0035871),1/10,0.06361635628304867,0.192288352927948,0,0,16.974358974358974,46.76240127804881,YOD1
organonitrogen compound catabolic process (GO:1901565),2/63,0.06418972283713609,0.19358345307091154,0,0,5.0344389376032534,13.824127105189065,ERAP1;LNPEP
apoptotic process (GO:0006915),4/231,0.06556870426084355,0.19495740637305783,0,0,2.7253113184640467,7.425537923473689,MYC;GAPDH;BCL2L1;HSPD1
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),2/64,0.06598443261380274,0.19495740637305783,0,0,4.952988247061765,13.463888410474983,YBX3;BCL2L1
pre-replicative complex assembly (GO:0036388),2/64,0.06598443261380274,0.19495740637305783,0,0,4.952988247061765,13.463888410474983,UBB;UBA52
regulation of cellular catabolic process (GO:0031329),2/65,0.06779583253668175,0.19495740637305783,0,0,4.874123292727944,13.117506503123318,PIP4K2A;DCAF12
chemical homeostasis (GO:0048878),2/65,0.06779583253668175,0.19495740637305783,0,0,4.874123292727944,13.117506503123318,WNK1;SLC4A1
regulation of RNA metabolic process (GO:0051252),2/65,0.06779583253668175,0.19495740637305783,0,0,4.874123292727944,13.117506503123318,RBM38;MBNL3
protein autoubiquitination (GO:0051865),2/65,0.06779583253668175,0.19495740637305783,0,0,4.874123292727944,13.117506503123318,RNF10;RNF11
regulation of intracellular signal transduction (GO:1902531),6/437,0.06787912468550021,0.19495740637305783,0,0,2.164788863109049,5.823339914638341,AKAP12;ARHGEF12;TP53INP1;PIP4K2A;HIPK1;OPTN
regulation of protein localization (GO:0032880),2/66,0.06962363089243005,0.19495740637305783,0,0,4.797722868217054,12.784258213722426,HSP90AA1;HSP90AB1
positive regulation of cell death (GO:0010942),2/66,0.06962363089243005,0.19495740637305783,0,0,4.797722868217054,12.784258213722426,HBA1;SNCA
actin filament depolymerization (GO:0030042),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,MICAL2
negative regulation of centrosome duplication (GO:0010826),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,NPM1
regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,ITM2A
regulation of biosynthetic process (GO:0009889),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,SNCA
axonal transport of mitochondrion (GO:0019896),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,TRAK2
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,FBXO7
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,SNCA
negative regulation of programmed necrotic cell death (GO:0062099),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,YBX3
negative regulation of receptor signaling pathway via STAT (GO:1904893),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,ADIPOR1
cellular response to superoxide (GO:0071451),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,PRDX2
regulation of lymphocyte migration (GO:2000401),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,MSN
regulation of mesenchymal cell proliferation (GO:0010464),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,MYC
regulation of mitochondrial fusion (GO:0010635),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,TFRC
regulation of phospholipase activity (GO:0010517),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,SNCA
positive regulation of alcohol biosynthetic process (GO:1902932),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,SNCA
establishment of epithelial cell apical/basal polarity (GO:0045198),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,MSN
positive regulation of cytoplasmic transport (GO:1903651),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,MSN
glutamine family amino acid biosynthetic process (GO:0009084),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,GLUL
interleukin-35-mediated signaling pathway (GO:0070757),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,CANX
positive regulation of myelination (GO:0031643),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,RNF10
isotype switching (GO:0045190),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,HSPD1
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,DDX5
tetrahydrobiopterin metabolic process (GO:0046146),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,HSP90AA1
mitochondrial transcription (GO:0006390),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,FOXO3
positive regulation of vacuole organization (GO:0044090),1/11,0.0697527247352707,0.19495740637305783,0,0,15.276153846153846,40.677324049781355,PIP4K2A
peptidyl-threonine modification (GO:0018210),2/67,0.07146753897988421,0.1993332611213472,0,0,4.723673225998807,12.463468172750613,WNK1;HIPK1
membrane organization (GO:0061024),4/242,0.07496395102913236,0.2055466771125391,0,0,2.5978958512538872,6.7304933092309,HSPA8;TFRC;UBB;UBA52
negative regulation of complement activation (GO:0045916),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,CR2
negative regulation of microtubule polymerization (GO:0031115),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,SNCA
catecholamine biosynthetic process (GO:0042423),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,SNCA
negative regulation of oxidoreductase activity (GO:0051354),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,SNCA
cellular response to nitrogen levels (GO:0043562),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,GABARAPL2
cellular response to nitrogen starvation (GO:0006995),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,GABARAPL2
neurotransmitter uptake (GO:0001504),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,GLUL
regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,WNK1
nuclear body organization (GO:0030575),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,SERBP1
glutamine metabolic process (GO:0006541),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,GLUL
positive regulation of sodium ion transmembrane transport (GO:1902307),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,WNK1
mitochondrion distribution (GO:0048311),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,TRAK2
mRNA transcription (GO:0009299),1/12,0.07584918549137858,0.2055466771125391,0,0,13.886713286713286,35.81394898804782,DDX5
positive regulation of multicellular organismal process (GO:0051240),5/345,0.07674485517583923,0.20755288768202676,0,0,2.279295051353875,5.851563363771565,TFRC;SCD;GNAS;ADIPOR1;GAPDH
cellular response to light stimulus (GO:0071482),2/70,0.07709308009174126,0.2076539415374321,0,0,4.514591883264934,11.569733125204282,NPM1;MYC
positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.07709308009174126,0.2076539415374321,0,0,4.514591883264934,11.569733125204282,DMTN;CDK6
positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.07854106599890219,0.20922831872196782,0,0,2.55443482787792,6.498823620821473,NPM1;TFRC;UBB;UBA52
negative regulation of cellular process (GO:0048523),7/566,0.07887101481655624,0.20922831872196782,0,0,1.9500548213976572,4.953025138311754,BNIP3L;NPM1;CDK6;BTG1;MYC;TP53INP1;TXNIP
negative regulation of neuron apoptotic process (GO:0043524),2/71,0.07899860044153495,0.20922831872196782,0,0,4.448938321536906,11.292851999442588,SET;CPEB4
nucleic acid metabolic process (GO:0090304),2/71,0.07899860044153495,0.20922831872196782,0,0,4.448938321536906,11.292851999442588,HNRNPK;HNRNPA2B1
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),2/71,0.07899860044153495,0.20922831872196782,0,0,4.448938321536906,11.292851999442588,HSP90AA1;HSP90AB1
positive regulation of cellular protein localization (GO:1903829),2/71,0.07899860044153495,0.20922831872196782,0,0,4.448938321536906,11.292851999442588,HSP90AB1;TFRC
negative regulation of transcription by RNA polymerase II (GO:0000122),8/684,0.08071639523444643,0.20922831872196782,0,0,1.8466349160533027,4.647635800018464,DDX5;UBB;MYC;MXI1;HDGF;FOXO3;UBA52;SNCA
negative regulation of supramolecular fiber organization (GO:1902904),2/72,0.08091883196264348,0.20922831872196782,0,0,4.38516057585825,11.025647392290939,HSPA8;SNCA
extrinsic apoptotic signaling pathway (GO:0097191),2/72,0.08091883196264348,0.20922831872196782,0,0,4.38516057585825,11.025647392290939,HIPK1;BCL2L1
Fc-gamma receptor signaling pathway (GO:0038094),2/72,0.08091883196264348,0.20922831872196782,0,0,4.38516057585825,11.025647392290939,HSP90AA1;HSP90AB1
positive regulation of neurogenesis (GO:0050769),2/72,0.08091883196264348,0.20922831872196782,0,0,4.38516057585825,11.025647392290939,CAPRIN1;NAP1L1
supramolecular fiber organization (GO:0097435),5/351,0.08122068222560408,0.20922831872196782,0,0,2.239081567116249,5.621405395609051,HSP90AB1;UBB;VIM;UBA52;SNCA
pteridine-containing compound metabolic process (GO:0042558),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,HSP90AA1
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,DMTN
negative regulation of cellular senescence (GO:2000773),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,CDK6
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,DMTN
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,SNCA
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,YOD1
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,SNCA
Golgi ribbon formation (GO:0090161),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,OPTN
response to iron ion (GO:0010039),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,SNCA
response to muramyl dipeptide (GO:0032495),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,VIM
ribosomal subunit export from nucleus (GO:0000054),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,NPM1
lipid oxidation (GO:0034440),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,ADIPOR1
positive regulation of protein localization to cell surface (GO:2000010),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,HSP90AB1
mitochondrial outer membrane permeabilization (GO:0097345),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,BNIP3L
mitochondrion transport along microtubule (GO:0047497),1/13,0.0819059960266386,0.20922831872196782,0,0,12.728846153846154,31.849903464460027,UBB
chromatin assembly (GO:0031497),2/73,0.08285350374808254,0.20955243894997147,0,0,4.3231793863958945,10.76766181968016,NPM1;NAP1L1
neurotransmitter transport (GO:0006836),2/73,0.08285350374808254,0.20955243894997147,0,0,4.3231793863958945,10.76766181968016,HSPA8;GLUL
transcription-coupled nucleotide-excision repair (GO:0006283),2/73,0.08285350374808254,0.20955243894997147,0,0,4.3231793863958945,10.76766181968016,UBB;UBA52
ubiquitin-dependent ERAD pathway (GO:0030433),2/73,0.08285350374808254,0.20955243894997147,0,0,4.3231793863958945,10.76766181968016,YOD1;STT3B
regulation of cell differentiation (GO:0045595),3/156,0.0830239113610387,0.20955243894997147,0,0,3.020220588235294,7.51620136619876,DDX5;CDK6;HSP90AB1
regulation of signal transduction by p53 class mediator (GO:1901796),3/156,0.0830239113610387,0.20955243894997147,0,0,3.020220588235294,7.51620136619876,TP53INP1;PIP4K2A;HIPK1
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",4/251,0.08313083281697971,0.20955243894997147,0,0,2.5020880487105104,6.223542719374629,HSPA8;DDX5;HNRNPK;HNRNPA2B1
proteolysis involved in cellular protein catabolic process (GO:0051603),2/74,0.08480234774984241,0.2125627328213686,0,0,4.262919896640827,10.51846518312765,UBB;UBA52
regulation of cytokine-mediated signaling pathway (GO:0001959),2/74,0.08480234774984241,0.2125627328213686,0,0,4.262919896640827,10.51846518312765,HSP90AB1;HIPK1
Fc receptor mediated stimulatory signaling pathway (GO:0002431),2/74,0.08480234774984241,0.2125627328213686,0,0,4.262919896640827,10.51846518312765,HSP90AA1;HSP90AB1
nucleic acid phosphodiester bond hydrolysis (GO:0090305),2/75,0.08676509873259489,0.2131863496389474,0,0,4.2043113518105555,10.277652789970434,UBB;UBA52
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),2/75,0.08676509873259489,0.2131863496389474,0,0,4.2043113518105555,10.277652789970434,UBB;UBA52
protein maturation by iron-sulfur cluster transfer (GO:0097428),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,GLRX5
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,ERAP1
negative regulation of translational initiation (GO:0045947),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,EIF2AK1
regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,DMTN
regulation of lamellipodium organization (GO:1902743),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,DMTN
regulation of lipase activity (GO:0060191),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,SNCA
dicarboxylic acid catabolic process (GO:0043649),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,GLUL
polarized epithelial cell differentiation (GO:0030859),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,MSN
regulation of response to interferon-gamma (GO:0060330),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,HSP90AB1
positive regulation of brown fat cell differentiation (GO:0090336),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,PIM1
positive regulation of cardiac muscle cell proliferation (GO:0060045),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,PIM1
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,NCL
positive regulation of lymphocyte migration (GO:2000403),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,DOCK8
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,WNK1
positive regulation of T cell chemotaxis (GO:0010820),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,WNK1
positive regulation of transmembrane transport (GO:0034764),1/14,0.08792341216396707,0.2131863496389474,0,0,11.749112426035502,28.565489678311135,CA2
regulation of epithelial to mesenchymal transition (GO:0010717),2/76,0.0887414943260991,0.21478013844142826,0,0,4.147286821705427,10.044843536296465,LDLRAD4;ADIPOR1
negative regulation of developmental process (GO:0051093),2/77,0.09073127492468111,0.2184089789177909,0,0,4.091782945736434,9.819678248913744,CDK6;TFRC
cellular response to UV (GO:0034644),2/77,0.09073127492468111,0.2184089789177909,0,0,4.091782945736434,9.819678248913744,NPM1;MYC
regulation of organelle assembly (GO:1902115),2/77,0.09073127492468111,0.2184089789177909,0,0,4.091782945736434,9.819678248913744,NPM1;MSN
"negative regulation of transcription, DNA-templated (GO:0045892)",10/948,0.09323100108434419,0.22125688771410637,0,0,1.667958906764877,3.957524370651686,HSPA8;DDX5;SET;UBB;MYC;MXI1;HDGF;FOXO3;UBA52;SNCA
androgen receptor signaling pathway (GO:0030521),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,DDX5
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,BCL2L1
cellular response to estrogen stimulus (GO:0071391),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,NCOA4
phosphatidylethanolamine biosynthetic process (GO:0006646),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,LPIN2
establishment of apical/basal cell polarity (GO:0035089),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,MSN
regulation of T cell chemotaxis (GO:0010819),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,WNK1
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,DDX5
integrated stress response signaling (GO:0140467),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,EIF2AK1
interleukin-27-mediated signaling pathway (GO:0070106),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,CANX
mitochondrial RNA metabolic process (GO:0000959),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,FOXO3
myoblast differentiation (GO:0045445),1/15,0.09390168812417539,0.22125688771410637,0,0,10.909340659340659,25.806120768156763,DDX5
protein transport (GO:0015031),5/369,0.09546503025710293,0.22454450778783364,0,0,2.1263954299668586,4.994892815375806,NPM1;TFRC;CANX;TXNIP;OPTN
negative regulation of cellular component organization (GO:0051129),2/80,0.09677837209693288,0.2256982710114915,0,0,3.933810375670841,9.186752223207284,HSPA8;RIOK3
response to interferon-gamma (GO:0034341),2/80,0.09677837209693288,0.2256982710114915,0,0,3.933810375670841,9.186752223207284,GAPDH;SNCA
regulation of protein phosphorylation (GO:0001932),4/266,0.09766973039730308,0.2256982710114915,0,0,2.357035523231352,5.482850214169827,HSP90AA1;NPM1;TFRC;FKBP8
protein deubiquitination (GO:0016579),4/267,0.09867904394766461,0.2256982710114915,0,0,2.3479536540822132,5.437585191019317,UBB;MYC;YOD1;UBA52
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/81,0.09881915169852733,0.2256982710114915,0,0,3.8838190560298305,8.988958804776345,HSPD1;SNCA
positive regulation of cellular amide metabolic process (GO:0034250),2/81,0.09881915169852733,0.2256982710114915,0,0,3.8838190560298305,8.988958804776345,NPM1;VIM
negative regulation of cell-substrate junction organization (GO:0150118),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,DMTN
negative regulation of focal adhesion assembly (GO:0051895),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,DMTN
regulation of cellular carbohydrate metabolic process (GO:0010675),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,ADIPOR1
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,ADIPOR1
negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,BCL2L1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,BCL2L1
regulation of isotype switching (GO:0045191),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,TFRC
nuclear transport (GO:0051169),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,NPM1
dendrite self-avoidance (GO:0070593),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,BSG
porphyrin-containing compound catabolic process (GO:0006787),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,BLVRB
positive regulation of collagen biosynthetic process (GO:0032967),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,VIM
glutamine family amino acid catabolic process (GO:0009065),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,GLUL
heme catabolic process (GO:0042167),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,BLVRB
positive regulation of immunoglobulin mediated immune response (GO:0002891),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,TFRC
positive regulation of isotype switching (GO:0045830),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,TFRC
killing by host of symbiont cells (GO:0051873),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,GAPDH
protein localization to endoplasmic reticulum (GO:0070972),1/16,0.09984107647289782,0.2256982710114915,0,0,10.181538461538462,23.460052416555833,GABARAPL2
peptide metabolic process (GO:0006518),2/83,0.10293685164162227,0.23191169273728052,0,0,3.787539477461958,8.611499627484111,ERAP1;LNPEP
regulation of osteoblast differentiation (GO:0045667),2/83,0.10293685164162227,0.23191169273728052,0,0,3.787539477461958,8.611499627484111,DDX5;CDK6
negative regulation of cell population proliferation (GO:0008285),5/379,0.1038963969397503,0.23224797736853328,0,0,2.068478906714201,4.683783089035317,NPM1;CDK6;BTG1;MYC;TP53INP1
anaphase-promoting complex-dependent catabolic process (GO:0031145),2/84,0.10501328789186029,0.23224797736853328,0,0,3.741160899981093,8.431336045283201,UBB;UBA52
nuclear export (GO:0051168),2/84,0.10501328789186029,0.23224797736853328,0,0,3.741160899981093,8.431336045283201,STRADB;XPO7
acyl-CoA biosynthetic process (GO:0071616),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,SCD
negative regulation of cell aging (GO:0090344),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,CDK6
negative regulation of execution phase of apoptosis (GO:1900118),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,BCL2L1
negative regulation of peptidyl-threonine phosphorylation (GO:0010801),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,DMTN
regulation of metal ion transport (GO:0010959),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,EPB41
positive regulation of blood coagulation (GO:0030194),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,DMTN
positive regulation of cardiac muscle tissue growth (GO:0055023),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,PIM1
positive regulation of collagen metabolic process (GO:0010714),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,VIM
gliogenesis (GO:0042063),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,CDK6
positive regulation of macrophage activation (GO:0043032),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,HSPD1
mitochondrial ATP synthesis coupled proton transport (GO:0042776),1/17,0.10574182820484038,0.23224797736853328,0,0,9.544711538461538,21.444625878565986,ATP5F1B
"mRNA splicing, via spliceosome (GO:0000398)",4/274,0.10588031395312644,0.23224797736853328,0,0,2.2862642169728784,5.133682695650228,HSPA8;DDX5;HNRNPK;HNRNPA2B1
B cell activation (GO:0042113),2/85,0.10710112995119657,0.23224797736853328,0,0,3.695899878584104,8.256572882844548,CR2;HSPD1
regulation of cell cycle G2/M phase transition (GO:1902749),2/85,0.10710112995119657,0.23224797736853328,0,0,3.695899878584104,8.256572882844548,HSP90AA1;NPM1
protein phosphorylation (GO:0006468),6/496,0.1077783285489139,0.23224797736853328,0,0,1.8983510204081633,4.228916085042465,CDK6;WNK1;EIF2AK1;STRADB;PIM1;HIPK1
protein modification by small protein removal (GO:0070646),4/276,0.10798094736542421,0.23224797736853328,0,0,2.269221861973136,5.050835111203106,UBB;MYC;YOD1;UBA52
regulation of neuron death (GO:1901214),2/86,0.10920014225785252,0.23224797736853328,0,0,3.65171650055371,8.086992447879068,UBB;SNCA
ERAD pathway (GO:0036503),2/87,0.11131009182500674,0.23224797736853328,0,0,3.608572731418149,7.9223881467273225,YOD1;STT3B
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),2/87,0.11131009182500674,0.23224797736853328,0,0,3.608572731418149,7.9223881467273225,UBB;UBA52
3'-UTR-mediated mRNA stabilization (GO:0070935),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,YBX3
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,DDX5
amyloid precursor protein metabolic process (GO:0042982),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,TMCC2
negative regulation of fibroblast proliferation (GO:0048147),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,MYC
regulation of brown fat cell differentiation (GO:0090335),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,PIM1
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,WNK1
regulation of early endosome to late endosome transport (GO:2000641),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,MSN
regulation of fatty acid metabolic process (GO:0019217),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,ADIPOR1
chromatin disassembly (GO:0031498),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,SET
nucleosome disassembly (GO:0006337),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,SET
regulation of platelet aggregation (GO:0090330),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,DMTN
regulation of presynapse assembly (GO:1905606),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,SNCA
regulation of presynapse organization (GO:0099174),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,SNCA
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,DDX5
regulation of protein-containing complex disassembly (GO:0043244),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,GSPT1
positive regulation of cell cycle phase transition (GO:1901989),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,NPM1
regulation of telomere maintenance via telomere lengthening (GO:1904356),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,HNRNPA2B1
release of cytochrome c from mitochondria (GO:0001836),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,BCL2L1
glycoprotein catabolic process (GO:0006516),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,STT3B
positive regulation of lymphocyte chemotaxis (GO:0140131),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,WNK1
intermediate filament organization (GO:0045109),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,VIM
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,NCL
positive regulation of myoblast differentiation (GO:0045663),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,BTG1
positive regulation of nervous system process (GO:0031646),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,RNF10
positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,HSP90AB1
T cell migration (GO:0072678),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,MSN
triglyceride biosynthetic process (GO:0019432),1/18,0.11160419271751376,0.23224797736853328,0,0,8.982805429864253,19.697465749311625,LPIN2
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/89,0.11556188328560123,0.236824655166828,0,0,3.5252606255012027,7.607333016908918,MYC;SNCA
regulation of type I interferon production (GO:0032479),2/89,0.11556188328560123,0.236824655166828,0,0,3.5252606255012027,7.607333016908918,G3BP1;GAPDH
transforming growth factor beta receptor signaling pathway (GO:0007179),2/89,0.11556188328560123,0.236824655166828,0,0,3.5252606255012027,7.607333016908918,UBB;UBA52
post-Golgi vesicle-mediated transport (GO:0006892),2/89,0.11556188328560123,0.236824655166828,0,0,3.5252606255012027,7.607333016908918,HSPA8;FTL
positive regulation of cellular process (GO:0048522),7/625,0.11665907193841817,0.236824655166828,0,0,1.758495145631068,3.778125963924603,RNF10;NPM1;HSP90AB1;MYC;NAP1L1;HBA1;EIF4G2
ATP synthesis coupled proton transport (GO:0015986),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,ATP5F1B
regulation of autophagy of mitochondrion (GO:1903146),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,FBXO7
branching involved in ureteric bud morphogenesis (GO:0001658),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,MYC
regulation of centriole replication (GO:0046599),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,NPM1
regulation of collagen biosynthetic process (GO:0032965),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,VIM
cellular response to copper ion (GO:0071280),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,SNCA
negative regulation of RNA metabolic process (GO:0051253),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,RPS26
negative regulation of RNA splicing (GO:0033119),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,RPS26
regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,BCL2L1
diol metabolic process (GO:0034311),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,HSP90AA1
dopamine metabolic process (GO:0042417),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,SNCA
regulation of stem cell population maintenance (GO:2000036),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,MYC
positive regulation of leukocyte activation (GO:0002696),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,HSPD1
ureteric bud morphogenesis (GO:0060675),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,MYC
mitochondrion localization (GO:0051646),1/19,0.11742841776762576,0.236824655166828,0,0,8.483333333333333,18.170675130648927,TRAK2
negative regulation of protein kinase activity (GO:0006469),2/90,0.11770327172962108,0.236824655166828,0,0,3.485024665257223,7.456518584163469,NPM1;SNCA
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),2/90,0.11770327172962108,0.236824655166828,0,0,3.485024665257223,7.456518584163469,RPS26;UBA52
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),3/185,0.12169193263816067,0.2420807432687498,0,0,2.5352421016483517,5.339885544864183,ANK1;SPTAN1;SPTB
regulation of lipid metabolic process (GO:0019216),2/92,0.12201591896200426,0.2420807432687498,0,0,3.407235142118863,7.167472654345803,SCD;ADIPOR1
T cell activation (GO:0042110),2/92,0.12201591896200426,0.2420807432687498,0,0,3.407235142118863,7.167472654345803,MSN;HSPD1
Wnt signaling pathway (GO:0016055),2/92,0.12201591896200426,0.2420807432687498,0,0,3.407235142118863,7.167472654345803,UBB;UBA52
phosphorylation (GO:0016310),5/400,0.12275821483653009,0.2420807432687498,0,0,1.9563994374120957,4.1036233198421534,CDK6;WNK1;STRADB;PIM1;HIPK1
regulation of granulocyte chemotaxis (GO:0071622),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,MPP1
cellular response to nitrogen compound (GO:1901699),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,RIOK3
regulation of programmed necrotic cell death (GO:0062098),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,HSP90AA1
regulation of protein kinase A signaling (GO:0010738),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,AKAP12
energy reserve metabolic process (GO:0006112),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,MYC
establishment of epithelial cell polarity (GO:0090162),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,MSN
regulation of T cell migration (GO:2000404),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,DOCK8
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,HSP90AB1
positive regulation of dendrite morphogenesis (GO:0050775),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,CAPRIN1
positive regulation of epithelial cell differentiation (GO:0030858),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,BTG1
positive regulation of interferon-alpha production (GO:0032727),1/20,0.12321474956792654,0.2420807432687498,0,0,8.036437246963562,16.82690539004688,HSPD1
regulation of epithelial cell proliferation (GO:0050678),2/93,0.12418673901548176,0.24363213410379386,0,0,3.369622625436579,7.028927955553716,CDK6;MYC
regulation of mitotic cell cycle phase transition (GO:1901990),3/188,0.126017395715834,0.2464616423207075,0,0,2.49375,5.16539245505662,HSP90AA1;UBB;UBA52
negative regulation of cell death (GO:0060548),2/94,0.12636693487251843,0.2464616423207075,0,0,3.3328277721604316,6.894172289267867,BNIP3L;SNCA
cotranslational protein targeting to membrane (GO:0006613),2/94,0.12636693487251843,0.2464616423207075,0,0,3.3328277721604316,6.894172289267867,RPS26;UBA52
interleukin-1-mediated signaling pathway (GO:0070498),2/94,0.12636693487251843,0.2464616423207075,0,0,3.3328277721604316,6.894172289267867,UBB;UBA52
mRNA metabolic process (GO:0016071),2/95,0.12855629313111225,0.24684118364763627,0,0,3.2968242060515127,6.763066905881875,DDX5;HNRNPA2B1
regulation of cardiac muscle cell proliferation (GO:0060043),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,PIM1
calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,DMTN
negative regulation of peptidyl-serine phosphorylation (GO:0033137),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,DMTN
negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,BCL2L1
negative regulation of protein localization to plasma membrane (GO:1903077),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,BCL2L1
cellular response to estradiol stimulus (GO:0071392),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,FAM210B
regulation of fibroblast migration (GO:0010762),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,DMTN
neuron apoptotic process (GO:0051402),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,GAPDH
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,BCL2L1
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,HIPK1
positive regulation of phosphatase activity (GO:0010922),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,HSP90AB1
stress granule assembly (GO:0034063),1/21,0.1289634327739896,0.24684118364763627,0,0,7.634230769230769,15.636632865318903,G3BP1
negative regulation of cell differentiation (GO:0045596),3/191,0.1303978865353088,0.24922972304888774,0,0,2.4535821143617023,4.99835120849238,CDK6;LDLRAD4;ADIPOR1
ribosome biogenesis (GO:0042254),3/192,0.13187000897719145,0.2516833314193254,0,0,2.4404761904761907,4.944254970568149,NPM1;GLUL;UBA52
mRNA processing (GO:0006397),4/300,0.13460892397920515,0.2523498080161546,0,0,2.0826771653543306,4.176562391113626,HSPA8;DDX5;HNRNPK;HNRNPA2B1
regulation of centrosome cycle (GO:0046605),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,NPM1
negative regulation of myeloid cell differentiation (GO:0045638),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,CDK6
regulation of chromosome organization (GO:0033044),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,MYC
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,BCL2L1
regulation of execution phase of apoptosis (GO:1900117),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,BCL2L1
cellular response to osmotic stress (GO:0071470),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,YBX3
fatty-acyl-CoA metabolic process (GO:0035337),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,SCD
positive regulation of dendritic spine development (GO:0060999),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,CAPRIN1
glutamate metabolic process (GO:0006536),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,GLUL
positive regulation of neural precursor cell proliferation (GO:2000179),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,NAP1L1
metallo-sulfur cluster assembly (GO:0031163),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,GLRX5
microglial cell activation (GO:0001774),1/22,0.13467471041580706,0.2523498080161546,0,0,7.27032967032967,14.576232777739394,SNCA
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/100,0.13963321569130813,0.2561557772291805,0,0,3.127827875336181,6.157867909881721,CANX;MARCHF8
acylglycerol biosynthetic process (GO:0046463),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,LPIN2
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,BCL2L1
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,SNCA
negative regulation of GTPase activity (GO:0034260),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,WNK1
negative regulation of intracellular protein transport (GO:0090317),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,DMTN
negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,BCL2L1
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,HSP90AB1
regulation of mononuclear cell migration (GO:0071675),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,MSN
regulation of neural precursor cell proliferation (GO:2000177),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,NAP1L1
ERK1 and ERK2 cascade (GO:0070371),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,MYC
positive regulation of cell cycle G2/M phase transition (GO:1902751),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,NPM1
regulation of supramolecular fiber organization (GO:1902903),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,HSPA8
response to copper ion (GO:0046688),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,SNCA
positive regulation of mRNA processing (GO:0050685),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,NCL
membrane protein ectodomain proteolysis (GO:0006509),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,ERAP1
positive regulation of transcription by RNA polymerase I (GO:0045943),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,NCL
vesicle transport along microtubule (GO:0047496),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,TRAK2
protein alkylation (GO:0008213),1/23,0.14034882405071863,0.2561557772291805,0,0,6.939510489510489,13.626591808289202,GSPT1
negative regulation of intracellular signal transduction (GO:1902532),3/198,0.14082425916852337,0.25667286527850913,0,0,2.3646634615384614,4.635313945249928,RIOK3;ADIPOR1;BCL2L1
intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.1441209130081196,0.2603975481150834,0,0,3.0649612403100774,5.937144565478081,DDX5;BCL2L1
positive regulation of vasculature development (GO:1904018),2/102,0.1441209130081196,0.2603975481150834,0,0,3.0649612403100774,5.937144565478081,BTG1;HIPK1
regulation of cell size (GO:0008361),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,MSN
canonical glycolysis (GO:0061621),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,GAPDH
negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,ADIPOR1
cellular response to catecholamine stimulus (GO:0071870),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,SNCA
defense response to fungus (GO:0050832),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,GAPDH
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,HSP90AB1
glucose catabolic process to pyruvate (GO:0061718),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,GAPDH
response to gamma radiation (GO:0010332),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,MYC
iron-sulfur cluster assembly (GO:0016226),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,GLRX5
positive regulation of neuron apoptotic process (GO:0043525),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,FOXO3
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,HSP90AB1
protein insertion into mitochondrial membrane (GO:0051204),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,HSP90AA1
protein K48-linked deubiquitination (GO:0071108),1/24,0.14598601360501082,0.2603975481150834,0,0,6.637458193979933,12.77209215219812,YOD1
protein targeting to ER (GO:0045047),2/103,0.14637616664253567,0.2603975481150834,0,0,3.034461585693453,5.83094699890265,RPS26;UBA52
cellular response to organonitrogen compound (GO:0071417),2/103,0.14637616664253567,0.2603975481150834,0,0,3.034461585693453,5.83094699890265,DMTN;CPEB4
chromatin remodeling (GO:0006338),2/103,0.14637616664253567,0.2603975481150834,0,0,3.034461585693453,5.83094699890265,NPM1;MYC
regulation of angiogenesis (GO:0045765),3/203,0.14843888612053033,0.26336567311690373,0,0,2.3049609375,4.396901872273551,BTG1;HIPK1;GLUL
axon guidance (GO:0007411),3/203,0.14843888612053033,0.26336567311690373,0,0,2.3049609375,4.396901872273551,BSG;SPTAN1;SPTB
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),6/547,0.15016689976976755,0.2640411831157617,0,0,1.7148687615526803,3.2514047850588494,HSPA8;SET;NCL;EIF2AK1;CAPRIN1;GAPDH
nucleotide-excision repair (GO:0006289),2/105,0.15090851911570427,0.2640411831157617,0,0,2.9752389553699103,5.626419225872187,UBB;UBA52
negative regulation of cell junction assembly (GO:1901889),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,DMTN
regulation of dopamine secretion (GO:0014059),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,SNCA
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,BCL2L1
negative regulation of signaling (GO:0023057),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,OPTN
regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,WNK1
regulation of interferon-alpha production (GO:0032647),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,HSPD1
divalent inorganic cation homeostasis (GO:0072507),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,SNCA
regulation of neutrophil chemotaxis (GO:0090022),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,MPP1
energy derivation by oxidation of organic compounds (GO:0015980),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,MYC
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,UBB
glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,GAPDH
response to dsRNA (GO:0043331),1/25,0.15158651755223743,0.2640411831157617,0,0,6.360576923076923,11.999856434705961,RIOK3
small GTPase mediated signal transduction (GO:0007264),2/106,0.15318523851381197,0.2664784878313187,0,0,2.9464818127608825,5.527916275920331,G3BP1;NUCB2
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,BCL2L1
clathrin-dependent endocytosis (GO:0072583),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,CANX
regulation of myelination (GO:0031641),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,RNF10
DNA geometric change (GO:0032392),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,HNRNPA2B1
endothelial cell development (GO:0001885),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,MSN
regulation of telomere maintenance (GO:0032204),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,MYC
glial cell development (GO:0021782),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,CDK6
positive regulation of ion transmembrane transporter activity (GO:0032414),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,WNK1
lamellipodium assembly (GO:0030032),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,DMTN
positive regulation of T cell mediated cytotoxicity (GO:0001916),1/26,0.15715057276342775,0.2698626802210019,0,0,6.105846153846154,11.29917891851374,CD1E
DNA replication (GO:0006260),2/108,0.1577588310879498,0.2705594330340192,0,0,2.890595290332017,5.338027050420404,SET;NAP1L1
negative regulation of gene expression (GO:0010629),4/322,0.16112979348654677,0.27511185056497467,0,0,1.936413608676274,3.535010313033282,RPS26;NCL;CAPRIN1;GAPDH
cellular response to oxygen-containing compound (GO:1901701),4/323,0.1623787729150367,0.27511185056497467,0,0,1.9302446128403228,3.508844150092722,FAM210B;DMTN;VIM;CPEB4
regulation of blood coagulation (GO:0030193),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,DMTN
negative regulation of insulin receptor signaling pathway (GO:0046627),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,PIP4K2A
cellular lipid catabolic process (GO:0044242),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,LPIN2
negative regulation of protein polymerization (GO:0032272),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,SNCA
positive regulation of calcium ion transmembrane transport (GO:1904427),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,SNCA
positive regulation of gene silencing by miRNA (GO:2000637),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,DDX5
melanosome organization (GO:0032438),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,HPS1
mitotic chromosome condensation (GO:0007076),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,SET
monocarboxylic acid catabolic process (GO:0072329),1/27,0.16267841463048652,0.27511185056497467,0,0,5.870710059171597,10.661091720478288,LPIN2
regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.16466686953321627,0.2773771483248784,0,0,2.810610909608136,5.069866577507228,CCNI;SNCA
negative regulation of multicellular organismal process (GO:0051241),3/214,0.16564250906104078,0.2773771483248784,0,0,2.1835752369668247,3.925900954686727,LNPEP;LDLRAD4;ADIPOR1
translation (GO:0006412),3/214,0.16564250906104078,0.2773771483248784,0,0,2.1835752369668247,3.925900954686727,RPS26;UBA52;GSPT1
regulation of macroautophagy (GO:0016241),2/112,0.16698154074413318,0.2773771483248784,0,0,2.78491895701198,4.984648483312149,BNIP3L;GAPDH
negative regulation of cellular response to insulin stimulus (GO:1900077),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,PIP4K2A
negative regulation of oxidative stress-induced cell death (GO:1903202),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,FBXO7
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,DDX5
cellular response to acid chemical (GO:0071229),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,CPEB4
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,BCL2L1
cristae formation (GO:0042407),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,ATP5F1B
regulation of plasma membrane bounded cell projection organization (GO:0120035),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,FBXO7
regulation of protein transport (GO:0051223),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,HSPA8
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,SNCA
regulation of small molecule metabolic process (GO:0062012),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,ADIPOR1
positive regulation of defense response to virus by host (GO:0002230),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,HSP90AA1
leukocyte cell-cell adhesion (GO:0007159),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,MSN
positive regulation of response to wounding (GO:1903036),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,DMTN
protein depolymerization (GO:0051261),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,MICAL2
protein localization to Golgi apparatus (GO:0034067),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,OPTN
protein localization to lysosome (GO:0061462),1/28,0.16817027705325713,0.2773771483248784,0,0,5.652991452991453,10.078030260645932,NCOA4
regulation of gene expression (GO:0010468),10/1079,0.1701156787309594,0.2802398850611119,0,0,1.4534321873381317,2.5744304379709555,RBM38;CDK6;HNRNPK;BTG1;TFRC;MYC;MSN;TRIM58;MBNL3;YBX3
regulation of cell growth (GO:0001558),3/217,0.17043446926312233,0.28041927455114707,0,0,2.1526358060747666,3.808883268234581,BTG1;TFRC;EIF4G2
cellular response to transforming growth factor beta stimulus (GO:0071560),2/114,0.17162782292474288,0.28048955289966554,0,0,2.734911406423034,4.820081614530397,UBB;UBA52
positive regulation of cellular component organization (GO:0051130),2/114,0.17162782292474288,0.28048955289966554,0,0,2.734911406423034,4.820081614530397,TFRC;SNCA
beta-catenin-TCF complex assembly (GO:1904837),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,MYC
negative regulation of mRNA catabolic process (GO:1902373),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,TENT5C
regulation of DNA biosynthetic process (GO:2000278),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,MYC
regulation of fatty acid biosynthetic process (GO:0042304),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,ADIPOR1
regulation of protein targeting to membrane (GO:0090313),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,DMTN
regulation of response to biotic stimulus (GO:0002831),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,ERAP1
establishment of endothelial barrier (GO:0061028),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,MSN
regulation of T cell mediated cytotoxicity (GO:0001914),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,CD1E
glycolytic process (GO:0006096),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,GAPDH
lamellipodium organization (GO:0097581),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,DMTN
transition metal ion homeostasis (GO:0055076),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,FTL
production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,HNRNPA2B1
protein K11-linked ubiquitination (GO:0070979),1/29,0.17362639240121513,0.28048955289966554,0,0,5.4508241758241756,9.543572555804772,UBE2H
positive regulation of protein metabolic process (GO:0051247),2/115,0.173959091548844,0.2806876163155261,0,0,2.7105714481717773,4.740613583223972,SLC25A37;OAZ1
positive regulation of angiogenesis (GO:0045766),2/116,0.17629555362932092,0.2827503318751558,0,0,2.686658506731946,4.662946800216381,BTG1;HIPK1
ion transport (GO:0006811),2/116,0.17629555362932092,0.2827503318751558,0,0,2.686658506731946,4.662946800216381,WNK1;SLC4A1
"transcription, DNA-templated (GO:0006351)",3/221,0.17688564770885457,0.2827503318751558,0,0,2.112707855504587,3.659742013746745,DDX5;FOXO3;PTMA
intracellular protein transport (GO:0006886),4/336,0.17893087978199132,0.2827503318751558,0,0,1.8534294658950763,3.189299307208197,NPM1;STRADB;XPO7;TRAK2
protein N-linked glycosylation via asparagine (GO:0018279),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,STT3B
regulation of catecholamine secretion (GO:0050433),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,SNCA
regulation of cation transmembrane transport (GO:1904062),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,WNK1
CENP-A containing chromatin organization (GO:0061641),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,NPM1
CENP-A containing nucleosome assembly (GO:0034080),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,NPM1
regulation of macrophage activation (GO:0043030),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,HSPD1
positive regulation of B cell proliferation (GO:0030890),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,TFRC
fatty-acyl-CoA biosynthetic process (GO:0046949),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,SCD
positive regulation of DNA recombination (GO:0045911),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,TFRC
regulation of type I interferon-mediated signaling pathway (GO:0060338),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,HSP90AB1
respiratory tube development (GO:0030323),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,HECA
Golgi to plasma membrane protein transport (GO:0043001),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,OPTN
positive regulation of phosphate metabolic process (GO:0045937),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,SNCA
synaptic vesicle cycle (GO:0099504),1/30,0.17904699159160314,0.2827503318751558,0,0,5.262599469496021,9.052234105349967,SNCA
protein palmitoylation (GO:0018345),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,GLUL
regulation of cellular component size (GO:0032535),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,MSN
regulation of cellular senescence (GO:2000772),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,CDK6
negative regulation of osteoblast differentiation (GO:0045668),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,CDK6
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,DMTN
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,HSP90AB1
cellular response to cAMP (GO:0071320),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,DMTN
negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,BCL2L1
peptidyl-asparagine modification (GO:0018196),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,STT3B
phosphatidylethanolamine metabolic process (GO:0046337),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,LPIN2
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,HSPD1
positive regulation of RNA splicing (GO:0033120),1/31,0.18443230402669894,0.28718130323970836,0,0,5.086923076923077,8.599305090496161,NCL
protein transmembrane import into intracellular organelle (GO:0044743),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,HSPD1
negative regulation of cell-matrix adhesion (GO:0001953),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,DMTN
regulation of cellular amide metabolic process (GO:0034248),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,FOXO3
regulation of cellular biosynthetic process (GO:0031326),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,ADIPOR1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,SNCA
regulation of centrosome duplication (GO:0010824),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,NPM1
regulation of dendrite morphogenesis (GO:0048814),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,CAPRIN1
regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,CAPRIN1
regulation of intracellular protein transport (GO:0033157),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,OAZ1
chromatin remodeling at centromere (GO:0031055),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,NPM1
ERBB2 signaling pathway (GO:0038128),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,HSP90AA1
response to amino acid (GO:0043200),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,CPEB4
positive regulation of interleukin-10 production (GO:0032733),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,HSPD1
intra-Golgi vesicle-mediated transport (GO:0006891),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,GABARAPL2
superoxide metabolic process (GO:0006801),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,PRDX2
positive regulation of telomere maintenance (GO:0032206),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,HNRNPA2B1
mitochondrial membrane organization (GO:0007006),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,BCL2L1
protein K63-linked deubiquitination (GO:0070536),1/32,0.18978255763675178,0.28944006507157577,0,0,4.922580645161291,8.18072008774948,YOD1
actin filament bundle assembly (GO:0051017),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,DMTN
actin filament bundle organization (GO:0061572),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,DMTN
phosphatidylcholine biosynthetic process (GO:0006656),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,LPIN2
regulation of protein localization to cell surface (GO:2000008),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,HSP90AB1
regulation of sprouting angiogenesis (GO:1903670),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,GLUL
RNA stabilization (GO:0043489),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,TENT5C
signal transduction by p53 class mediator (GO:0072331),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,DDX5
lytic vacuole organization (GO:0080171),1/33,0.1950979789430415,0.29460635988518635,0,0,4.768509615384615,7.792953006521877,HPS1
fatty acid metabolic process (GO:0006631),2/124,0.19515466204969303,0.29460635988518635,0,0,2.5094675308171306,4.100376834248377,ADIPOR1;LPIN2
protein targeting (GO:0006605),2/125,0.19753061042224657,0.29778205493406223,0,0,2.488939307997731,4.036715380003251,FBXO7;TRAK2
positive regulation of cell population proliferation (GO:0008284),5/474,0.2002126901456296,0.29778205493406223,0,0,1.6414526009408739,2.640071370978491,NPM1;CDK6;MYC;PIM1;NAP1L1
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,BCL2L1
autophagosome maturation (GO:0097352),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,GABARAPL2
cellular response to amino acid stimulus (GO:0071230),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,CPEB4
regulation of glucose metabolic process (GO:0010906),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,ADIPOR1
regulation of lamellipodium assembly (GO:0010591),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,DMTN
regulation of myoblast differentiation (GO:0045661),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,BTG1
positive regulation of calcium ion transport into cytosol (GO:0010524),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,SNCA
positive regulation of interleukin-12 production (GO:0032735),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,HSPD1
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,FOXO3
positive regulation of protein dephosphorylation (GO:0035307),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,HSP90AB1
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,SNCA
protein destabilization (GO:0031648),1/34,0.2003787929533847,0.29778205493406223,0,0,4.623776223776224,7.432931766422354,SNCA
negative regulation of cell cycle G1/S phase transition (GO:1902807),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,CDK6
negative regulation of epithelial cell migration (GO:0010633),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,ADIPOR1
regulation of autophagosome assembly (GO:2000785),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,PIP4K2A
regulation of ion transmembrane transport (GO:0034765),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,WNK1
regulation of lipid biosynthetic process (GO:0046890),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,ADIPOR1
regulation of protein polymerization (GO:0032271),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,HSP90AA1
response to estrogen (GO:0043627),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,NCOA4
positive regulation of immunoglobulin production (GO:0002639),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,TFRC
positive regulation of lymphocyte activation (GO:0051251),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,HSPD1
smoothened signaling pathway (GO:0007224),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,HIPK1
maturation of SSU-rRNA (GO:0030490),1/35,0.2056252232488539,0.30188494314337233,0,0,4.487556561085973,7.097968534671513,RIOK3
DNA-dependent DNA replication (GO:0006261),2/129,0.20706908728534631,0.30367102152933334,0,0,2.4100592077153147,3.795126949775646,UBB;UBA52
G2/M transition of mitotic cell cycle (GO:0000086),2/130,0.2094616514097493,0.3048472828195015,0,0,2.391109496124031,3.737817285392478,HSP90AA1;OPTN
regulation of androgen receptor signaling pathway (GO:0060765),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,DDX5
regulation of defense response to virus by host (GO:0050691),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,HSP90AA1
regulation of mRNA processing (GO:0050684),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,HNRNPK
platelet aggregation (GO:0070527),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,GNAS
establishment of protein localization to plasma membrane (GO:0061951),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,OPTN
regulation of sodium ion transport (GO:0002028),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,WNK1
positive regulation of innate immune response (GO:0045089),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,RIOK3
macrophage activation (GO:0042116),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,SNCA
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,DMTN
transferrin transport (GO:0033572),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,TFRC
transition metal ion transport (GO:0000041),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,TFRC
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.21083749200989477,0.3048472828195015,0,0,4.359120879120879,6.785702334197538,HNRNPA2B1
cell cycle G2/M phase transition (GO:0044839),2/131,0.21185710915161968,0.30565993285806037,0,0,2.372453578510907,3.681676059876496,HSP90AA1;OPTN
cellular response to metal ion (GO:0071248),2/131,0.21185710915161968,0.30565993285806037,0,0,2.372453578510907,3.681676059876496,DMTN;SNCA
proton transmembrane transport (GO:1902600),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,ATP5F1B
anterograde axonal transport (GO:0008089),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,TRAK2
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,CDK6
negative regulation of stress-activated MAPK cascade (GO:0032873),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,MYC
centromere complex assembly (GO:0034508),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,NPM1
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,DDX5
glutamate receptor signaling pathway (GO:0007215),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,CPEB4
glutamine family amino acid metabolic process (GO:0009064),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,GLUL
positive regulation of exocytosis (GO:0045921),1/37,0.2160158199701249,0.30866003794661695,0,0,4.237820512820512,6.49405155144787,SNCA
RNA metabolic process (GO:0016070),2/133,0.21665615030978333,0.3092442487327677,0,0,2.335996212793656,3.5727747912595587,HNRNPK;HNRNPA2B1
actin-myosin filament sliding (GO:0033275),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,VIM
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,HSP90AB1
regulation of phosphoprotein phosphatase activity (GO:0043666),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,HSP90AB1
positive regulation of cell development (GO:0010720),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,NAP1L1
response to cAMP (GO:0051591),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,DMTN
response to estradiol (GO:0032355),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,FAM210B
histone exchange (GO:0043486),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,NPM1
lysosome organization (GO:0007040),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,HPS1
positive regulation of signaling (GO:0023056),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,SNCA
muscle filament sliding (GO:0030049),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,VIM
ncRNA export from nucleus (GO:0097064),1/38,0.22116042647143752,0.31200668401883896,0,0,4.123076923076923,6.221174415676765,NPM1
protein localization to plasma membrane (GO:0072659),2/136,0.2238729880649152,0.3148945450535834,0,0,2.2833506884183734,3.417437100860096,BSG;ANK1
ribonucleoprotein complex assembly (GO:0022618),2/136,0.2238729880649152,0.3148945450535834,0,0,2.2833506884183734,3.417437100860096,HSP90AA1;HSP90AB1
positive regulation of protein phosphorylation (GO:0001934),4/371,0.22603326916747915,0.3148945450535834,0,0,1.673668175674226,2.488866891974606,HSP90AA1;HSP90AB1;TFRC;SNCA
negative regulation of cellular metabolic process (GO:0031324),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,OPTN
negative regulation of secretion by cell (GO:1903531),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,SNCA
regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,HSP90AA1
DNA replication-independent nucleosome assembly (GO:0006336),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,NPM1
regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,DMTN
regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,HNRNPK
positive regulation of intracellular transport (GO:0032388),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,OAZ1
membrane protein proteolysis (GO:0033619),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,ERAP1
vesicle cytoskeletal trafficking (GO:0099518),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,TRAK2
protein acylation (GO:0043543),1/39,0.22627152937982042,0.3148945450535834,0,0,4.014372469635627,5.965435944563848,GLUL
negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,DMTN
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,RIOK3
bone development (GO:0060348),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,GNAS
nucleocytoplasmic transport (GO:0006913),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,NPM1
regulation of microtubule polymerization (GO:0031113),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,SNCA
regulation of sodium ion transmembrane transporter activity (GO:2000649),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,WNK1
fatty acid derivative biosynthetic process (GO:1901570),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,SCD
lymphocyte migration (GO:0072676),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,MSN
synaptic vesicle exocytosis (GO:0016079),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,SNCA
positive regulation of wound healing (GO:0090303),1/40,0.23134934524843717,0.31864198479578565,0,0,3.911242603550296,5.725380155504451,DMTN
protein localization to cell periphery (GO:1990778),2/140,0.2335240174000492,0.32128433689579444,0,0,2.2167172227839567,3.2241494724760296,BSG;ANK1
regulation of cell population proliferation (GO:0042127),7/764,0.2350414012192171,0.32128433689579444,0,0,1.4252354369966336,2.063731798325113,NPM1;CDK6;BTG1;TFRC;MYC;TP53INP1;NAP1L1
protein methylation (GO:0006479),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,GSPT1
negative regulation of cell-cell adhesion (GO:0022408),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,WNK1
carbohydrate catabolic process (GO:0016052),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,GAPDH
regulation of filopodium assembly (GO:0051489),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,DMTN
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,BCL2L1
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,MYC
gluconeogenesis (GO:0006094),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,GAPDH
response to growth factor (GO:0070848),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,MYC
import into cell (GO:0098657),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,GLUL
keratinocyte differentiation (GO:0030216),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,TXNIP
visual system development (GO:0150063),1/41,0.23639408919802837,0.32128433689579444,0,0,3.813269230769231,5.499706603575161,HIPK1
chromatin organization (GO:0006325),2/142,0.23835948622470318,0.3232977396915771,0,0,2.184828349944629,3.1329898854252516,NPM1;MYC
protein localization to organelle (GO:0033365),2/142,0.23835948622470318,0.3232977396915771,0,0,2.184828349944629,3.1329898854252516,GABARAPL2;OPTN
negative regulation of protein catabolic process (GO:0042177),1/42,0.24140597496207092,0.3254474092324185,0,0,3.720075046904315,5.287250478221397,SNCA
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.24140597496207092,0.3254474092324185,0,0,3.720075046904315,5.287250478221397,BCL2L1
nucleic acid-templated transcription (GO:0097659),1/42,0.24140597496207092,0.3254474092324185,0,0,3.720075046904315,5.287250478221397,PTMA
phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.24140597496207092,0.3254474092324185,0,0,3.720075046904315,5.287250478221397,PIP4K2A
positive regulation of ATPase activity (GO:0032781),1/42,0.24140597496207092,0.3254474092324185,0,0,3.720075046904315,5.287250478221397,GABARAPL2
mitochondrial gene expression (GO:0140053),1/42,0.24140597496207092,0.3254474092324185,0,0,3.720075046904315,5.287250478221397,FOXO3
positive regulation of nucleic acid-templated transcription (GO:1903508),5/511,0.24403369976736938,0.3286582892028281,0,0,1.5185237467846164,2.141800223329389,RNF10;NPM1;MYC;TP53INP1;FOXO3
positive regulation of macromolecule metabolic process (GO:0010604),4/384,0.24429783844588512,0.3286826910007075,0,0,1.6153336096145876,2.2765981235935797,TFRC;MYC;MSN;SNCA
positive regulation of transcription by RNA polymerase II (GO:0045944),8/908,0.24490975291015982,0.3291706471359496,0,0,1.370840108401084,1.9285876432378173,RNF10;NPM1;UBB;MYC;MICAL2;FOXO3;UBA52;LPIN2
anion transport (GO:0006820),1/43,0.24638521492211796,0.3291706471359496,0,0,3.6313186813186813,5.086965650860344,SLC4A1
regulation of cell-substrate adhesion (GO:0010810),1/43,0.24638521492211796,0.3291706471359496,0,0,3.6313186813186813,5.086965650860344,DMTN
development of primary male sexual characteristics (GO:0046546),1/43,0.24638521492211796,0.3291706471359496,0,0,3.6313186813186813,5.086965650860344,NCOA4
heart looping (GO:0001947),1/43,0.24638521492211796,0.3291706471359496,0,0,3.6313186813186813,5.086965650860344,MICAL2
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.24638521492211796,0.3291706471359496,0,0,3.6313186813186813,5.086965650860344,CD1E
male gonad development (GO:0008584),1/43,0.24638521492211796,0.3291706471359496,0,0,3.6313186813186813,5.086965650860344,NCOA4
branching morphogenesis of an epithelial tube (GO:0048754),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,MYC
positive regulation of biosynthetic process (GO:0009891),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,VIM
positive regulation of cell-matrix adhesion (GO:0001954),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,CDK6
hexose biosynthetic process (GO:0019319),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,GAPDH
homotypic cell-cell adhesion (GO:0034109),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,GNAS
intracellular protein transmembrane transport (GO:0065002),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,HSPD1
positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,WNK1
positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,HNRNPK
metal ion homeostasis (GO:0055065),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,SNCA
mRNA catabolic process (GO:0006402),1/44,0.2513320201385109,0.332455028618862,0,0,3.5466905187835422,4.897910178444639,DDX5
regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.2562466002167321,0.33695419083617534,0,0,3.465909090909091,4.719233862496041,PIP4K2A
chromosome condensation (GO:0030261),1/45,0.2562466002167321,0.33695419083617534,0,0,3.465909090909091,4.719233862496041,SET
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),1/45,0.2562466002167321,0.33695419083617534,0,0,3.465909090909091,4.719233862496041,ADIPOR1
positive regulation of nervous system development (GO:0051962),1/45,0.2562466002167321,0.33695419083617534,0,0,3.465909090909091,4.719233862496041,NAP1L1
positive regulation of response to biotic stimulus (GO:0002833),1/45,0.2562466002167321,0.33695419083617534,0,0,3.465909090909091,4.719233862496041,RIOK3
positive regulation of RNA metabolic process (GO:0051254),1/45,0.2562466002167321,0.33695419083617534,0,0,3.465909090909091,4.719233862496041,DDX5
response to cytokine (GO:0034097),2/150,0.25774514997166736,0.33859146544950597,0,0,2.065891472868217,2.80090254898543,BCL2L1;SNCA
alpha-amino acid metabolic process (GO:1901605),1/46,0.2611291635111755,0.34102498773306983,0,0,3.388717948717949,4.5501675272107995,GLUL
regulation of B cell proliferation (GO:0030888),1/46,0.2611291635111755,0.34102498773306983,0,0,3.388717948717949,4.5501675272107995,TFRC
regulation of DNA metabolic process (GO:0051052),1/46,0.2611291635111755,0.34102498773306983,0,0,3.388717948717949,4.5501675272107995,MYC
establishment of protein localization to extracellular region (GO:0035592),1/46,0.2611291635111755,0.34102498773306983,0,0,3.388717948717949,4.5501675272107995,CANX
positive regulation of response to stimulus (GO:0048584),1/46,0.2611291635111755,0.34102498773306983,0,0,3.388717948717949,4.5501675272107995,MYC
posttranscriptional regulation of gene expression (GO:0010608),1/46,0.2611291635111755,0.34102498773306983,0,0,3.388717948717949,4.5501675272107995,FOXO3
negative regulation of cold-induced thermogenesis (GO:0120163),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,LNPEP
determination of heart left/right asymmetry (GO:0061371),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,MICAL2
embryonic heart tube morphogenesis (GO:0003143),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,MICAL2
epithelial to mesenchymal transition (GO:0001837),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,DDX5
regulation of synapse assembly (GO:0051963),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,SNCA
regulation of T cell activation (GO:0050863),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,HSPD1
regulation of wound healing (GO:0061041),1/47,0.2659799169914363,0.34499919330151346,0,0,3.3148829431438127,4.390013755839864,DMTN
cellular response to interleukin-1 (GO:0071347),2/155,0.26987825311019525,0.34955319087925074,0,0,1.9978720170238637,2.6167814733962427,UBB;UBA52
regulation of interleukin-10 production (GO:0032653),1/48,0.2707990662874435,0.34955319087925074,0,0,3.244189852700491,4.238138854578135,HSPD1
regulation of protein metabolic process (GO:0051246),1/48,0.2707990662874435,0.34955319087925074,0,0,3.244189852700491,4.238138854578135,HSP90AB1
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.2707990662874435,0.34955319087925074,0,0,3.244189852700491,4.238138854578135,ATP5F1B
Golgi to plasma membrane transport (GO:0006893),1/48,0.2707990662874435,0.34955319087925074,0,0,3.244189852700491,4.238138854578135,OPTN
peptidyl-serine phosphorylation (GO:0018105),2/156,0.27230493300915015,0.35115771283805464,0,0,1.9847981475888452,2.581890459088312,WNK1;HIPK1
DNA metabolic process (GO:0006259),3/277,0.272692355579308,0.35131821316678447,0,0,1.6761234032846715,2.17797322424115,NPM1;UBB;UBA52
regulation of cellular protein metabolic process (GO:0032268),1/49,0.27558681582982053,0.35368298362021156,0,0,3.176442307692308,4.093965860472672,FOXO3
regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.27558681582982053,0.35368298362021156,0,0,3.176442307692308,4.093965860472672,MYC
inner mitochondrial membrane organization (GO:0007007),1/49,0.27558681582982053,0.35368298362021156,0,0,3.176442307692308,4.093965860472672,ATP5F1B
mitotic cytokinesis (GO:0000281),1/49,0.27558681582982053,0.35368298362021156,0,0,3.176442307692308,4.093965860472672,SEPTIN6
organonitrogen compound biosynthetic process (GO:1901566),2/158,0.2771575295913118,0.3553574467696666,0,0,1.9591532498509243,2.5139251779504668,ALAS2;LPIN2
response to lipopolysaccharide (GO:0032496),2/159,0.2795832466317718,0.35704360373103516,0,0,1.9465758159285045,2.4808236503152723,VIM;SNCA
protein autophosphorylation (GO:0046777),2/159,0.2795832466317718,0.35704360373103516,0,0,1.9465758159285045,2.4808236503152723,EIF2AK1;PIM1
actin polymerization or depolymerization (GO:0008154),1/50,0.28034336849839514,0.35704360373103516,0,0,3.111459968602826,3.956968446025251,MICAL2
regulation of cellular component movement (GO:0051270),1/50,0.28034336849839514,0.35704360373103516,0,0,3.111459968602826,3.956968446025251,CDK6
regulation of complement activation (GO:0030449),1/50,0.28034336849839514,0.35704360373103516,0,0,3.111459968602826,3.956968446025251,CR2
ribosome assembly (GO:0042255),1/50,0.28034336849839514,0.35704360373103516,0,0,3.111459968602826,3.956968446025251,NPM1
iron ion transport (GO:0006826),1/50,0.28034336849839514,0.35704360373103516,0,0,3.111459968602826,3.956968446025251,TFRC
positive regulation of protein kinase B signaling (GO:0051897),2/161,0.2844330288601587,0.35997361560026536,0,0,1.9218955682316805,2.4163175262082346,HSP90AA1;HSP90AB1
regulation of cellular amine metabolic process (GO:0033238),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,OAZ1
negative regulation of transport (GO:0051051),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,SNCA
regulation of interleukin-12 production (GO:0032655),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,HSPD1
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,DMTN
positive regulation of fat cell differentiation (GO:0045600),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,PIM1
gonad development (GO:0008406),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,NCOA4
sensory perception (GO:0007600),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,GNAS
mesenchymal cell differentiation (GO:0048762),1/51,0.28506892612655743,0.35997361560026536,0,0,3.0490769230769232,3.8266655758285544,DDX5
peptide biosynthetic process (GO:0043043),2/162,0.28685690210971354,0.3618893495926131,0,0,1.9097868217054264,2.384887901146881,RPS26;GSPT1
positive regulation of intracellular signal transduction (GO:1902533),5/546,0.2876080557185932,0.36249468154720804,0,0,1.4177155766804566,1.7666956843028414,HSP90AA1;HSP90AB1;TFRC;GAPDH;BCL2L1
regulation of exocytosis (GO:0017157),1/52,0.2897636891206341,0.3634969846621288,0,0,2.9891402714932127,3.7026168276048637,SNCA
regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.2897636891206341,0.3634969846621288,0,0,2.9891402714932127,3.7026168276048637,BCL2L1
plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.2897636891206341,0.3634969846621288,0,0,2.9891402714932127,3.7026168276048637,UBB
regulation of release of sequestered calcium ion into cytosol (GO:0051279),1/52,0.2897636891206341,0.3634969846621288,0,0,2.9891402714932127,3.7026168276048637,SNCA
positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.2897636891206341,0.3634969846621288,0,0,2.9891402714932127,3.7026168276048637,EPB41
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),2/165,0.2941233251490063,0.36693620934850585,0,0,1.8743520235887192,2.2937497717129522,AKAP12;GNAS
negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.29442785660299275,0.36693620934850585,0,0,2.931508875739645,3.5844182701898526,SNCA
cellular macromolecule catabolic process (GO:0044265),1/53,0.29442785660299275,0.36693620934850585,0,0,2.931508875739645,3.5844182701898526,STT3B
regulation of immune effector process (GO:0002697),1/53,0.29442785660299275,0.36693620934850585,0,0,2.931508875739645,3.5844182701898526,CR2
epidermal cell differentiation (GO:0009913),1/53,0.29442785660299275,0.36693620934850585,0,0,2.931508875739645,3.5844182701898526,TXNIP
positive regulation of B cell activation (GO:0050871),1/53,0.29442785660299275,0.36693620934850585,0,0,2.931508875739645,3.5844182701898526,TFRC
IRE1-mediated unfolded protein response (GO:0036498),1/53,0.29442785660299275,0.36693620934850585,0,0,2.931508875739645,3.5844182701898526,HDGF
regulation of cellular amino acid metabolic process (GO:0006521),1/54,0.29906162642283773,0.3709808104929538,0,0,2.8760522496371554,3.471698829323926,OAZ1
regulation of focal adhesion assembly (GO:0051893),1/54,0.29906162642283773,0.3709808104929538,0,0,2.8760522496371554,3.471698829323926,DMTN
regulation of humoral immune response (GO:0002920),1/54,0.29906162642283773,0.3709808104929538,0,0,2.8760522496371554,3.471698829323926,CR2
inorganic anion transport (GO:0015698),1/54,0.29906162642283773,0.3709808104929538,0,0,2.8760522496371554,3.471698829323926,SLC4A1
unsaturated fatty acid metabolic process (GO:0033559),1/54,0.29906162642283773,0.3709808104929538,0,0,2.8760522496371554,3.471698829323926,SCD
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/55,0.3036651952121775,0.3751127178731488,0,0,2.822649572649573,3.3641170740820274,SNCA
regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.3036651952121775,0.3751127178731488,0,0,2.822649572649573,3.3641170740820274,ATP5F1B
glycoprotein metabolic process (GO:0009100),1/55,0.3036651952121775,0.3751127178731488,0,0,2.822649572649573,3.3641170740820274,STT3B
triglyceride metabolic process (GO:0006641),1/55,0.3036651952121775,0.3751127178731488,0,0,2.822649572649573,3.3641170740820274,LPIN2
peptidyl-serine modification (GO:0018209),2/169,0.3037963777984633,0.3751127178731488,0,0,1.8290860140184746,2.1791687090105323,WNK1;HIPK1
negative regulation of metabolic process (GO:0009892),1/56,0.3082387582984377,0.3795456046882145,0,0,2.771188811188811,3.2613583703120255,LNPEP
chemokine-mediated signaling pathway (GO:0070098),1/56,0.3082387582984377,0.3795456046882145,0,0,2.771188811188811,3.2613583703120255,WNK1
sensory organ development (GO:0007423),1/56,0.3082387582984377,0.3795456046882145,0,0,2.771188811188811,3.2613583703120255,HIPK1
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/171,0.30862467795524734,0.379670874537947,0,0,1.8072565478647769,2.124663885468982,TFRC;GAPDH
DNA repair (GO:0006281),3/298,0.3101452999138693,0.3811905434083987,0,0,1.5551377118644067,1.820622085135412,NPM1;UBB;UBA52
cellular response to peptide (GO:1901653),1/57,0.31278250973806404,0.38267164195059855,0,0,2.721565934065934,3.163132351195512,VIM
regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.31278250973806404,0.38267164195059855,0,0,2.721565934065934,3.163132351195512,SNCA
positive regulation of interferon-gamma production (GO:0032729),1/57,0.31278250973806404,0.38267164195059855,0,0,2.721565934065934,3.163132351195512,HSPD1
ribosomal large subunit biogenesis (GO:0042273),1/57,0.31278250973806404,0.38267164195059855,0,0,2.721565934065934,3.163132351195512,NPM1
protein K48-linked ubiquitination (GO:0070936),1/57,0.31278250973806404,0.38267164195059855,0,0,2.721565934065934,3.163132351195512,UBE2H
rRNA processing (GO:0006364),2/173,0.3134465930813446,0.3831332555870781,0,0,1.7859377124983,2.0719132933198137,RIOK3;UBA52
negative regulation of hydrolase activity (GO:0051346),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,WNK1
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,LDLRAD4
eye development (GO:0001654),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,HIPK1
fat cell differentiation (GO:0045444),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,ERAP1
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,HIPK1
positive regulation of mitochondrion organization (GO:0010822),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,FBXO7
positive regulation of protein binding (GO:0032092),1/58,0.3172966423848577,0.38503806883661756,0,0,2.6736842105263157,3.069170665465753,EPB41
innate immune response (GO:0045087),3/302,0.31731056421341014,0.38503806883661756,0,0,1.5340196488294315,1.760861710431563,CR2;TRIM58;SNCA
positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.32178134786200596,0.3897551049353037,0,0,2.627453580901857,2.979224969691473,BCL2L1
fatty acid oxidation (GO:0019395),1/59,0.32178134786200596,0.3897551049353037,0,0,2.627453580901857,2.979224969691473,ADIPOR1
positive regulation of developmental process (GO:0051094),2/177,0.3230686746656884,0.39060610801209017,0,0,1.7447619047619047,1.9713896624343719,HSP90AB1;TFRC
glycerophospholipid biosynthetic process (GO:0046474),2/177,0.3230686746656884,0.39060610801209017,0,0,1.7447619047619047,1.9713896624343719,PIP4K2A;LPIN2
regulation of mitotic cell cycle (GO:0007346),2/178,0.32546920591785894,0.3926598078917567,0,0,1.7347603946441155,1.947246732338217,BTG1;HECA
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.32623681643701347,0.3926598078917567,0,0,2.5827900912646675,2.8930651345761484,AKAP12
cellular protein catabolic process (GO:0044257),1/60,0.32623681643701347,0.3926598078917567,0,0,2.5827900912646675,2.8930651345761484,BNIP3L
Notch signaling pathway (GO:0007219),1/60,0.32623681643701347,0.3926598078917567,0,0,2.5827900912646675,2.8930651345761484,MYC
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.32623681643701347,0.3926598078917567,0,0,2.5827900912646675,2.8930651345761484,BSG
RNA processing (GO:0006396),2/179,0.3278675887480608,0.39426741545221355,0,0,1.7248718959400866,1.923483037871514,HNRNPK;HNRNPA2B1
B cell differentiation (GO:0030183),1/61,0.3306632373744845,0.3958477465343291,0,0,2.539615384615385,2.8104776349330467,CR2
regulation of endocytosis (GO:0030100),1/61,0.3306632373744845,0.3958477465343291,0,0,2.539615384615385,2.8104776349330467,SNCA
negative regulation of response to stimulus (GO:0048585),1/61,0.3306632373744845,0.3958477465343291,0,0,2.539615384615385,2.8104776349330467,CDK6
response to light stimulus (GO:0009416),1/61,0.3306632373744845,0.3958477465343291,0,0,2.539615384615385,2.8104776349330467,FECH
protein lipidation (GO:0006497),1/61,0.3306632373744845,0.3958477465343291,0,0,2.539615384615385,2.8104776349330467,GLUL
negative regulation of kinase activity (GO:0033673),1/62,0.3350607985306605,0.3996796668187165,0,0,2.4978562421185373,2.731264111042341,SNCA
regulation of neurogenesis (GO:0050767),1/62,0.3350607985306605,0.3996796668187165,0,0,2.4978562421185373,2.731264111042341,NAP1L1
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.3350607985306605,0.3996796668187165,0,0,2.4978562421185373,2.731264111042341,MYC
glucose metabolic process (GO:0006006),1/62,0.3350607985306605,0.3996796668187165,0,0,2.4978562421185373,2.731264111042341,GAPDH
actin cytoskeleton reorganization (GO:0031532),1/63,0.3394296866616383,0.4034502325444384,0,0,2.4574441687344915,2.6552400701818284,DMTN
negative regulation of endopeptidase activity (GO:0010951),1/63,0.3394296866616383,0.4034502325444384,0,0,2.4574441687344915,2.6552400701818284,GAPDH
negative regulation of peptidase activity (GO:0010466),1/63,0.3394296866616383,0.4034502325444384,0,0,2.4574441687344915,2.6552400701818284,GAPDH
positive regulation of DNA metabolic process (GO:0051054),1/63,0.3394296866616383,0.4034502325444384,0,0,2.4574441687344915,2.6552400701818284,MYC
protein secretion (GO:0009306),1/64,0.34377008725903546,0.40752159412428696,0,0,2.418315018315018,2.5822337209874426,CANX
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.34377008725903546,0.40752159412428696,0,0,2.418315018315018,2.5822337209874426,GAPDH
regulation of cellular ketone metabolic process (GO:0010565),1/64,0.34377008725903546,0.40752159412428696,0,0,2.418315018315018,2.5822337209874426,OAZ1
BMP signaling pathway (GO:0030509),1/65,0.34808218466161406,0.4119023903524503,0,0,2.3804086538461537,2.512084920173941,DDX5
regulation of cell-matrix adhesion (GO:0001952),1/65,0.34808218466161406,0.4119023903524503,0,0,2.3804086538461537,2.512084920173941,CDK6
regulation of GTPase activity (GO:0043087),2/189,0.35171737815318116,0.41476757050607116,0,0,1.6318036728433445,1.70511625308354,WNK1;DOCK8
cellular component disassembly (GO:0022411),1/66,0.3523661620691548,0.41476757050607116,0,0,2.3436686390532544,2.444644221713126,BSG
cellular response to nutrient levels (GO:0031669),1/66,0.3523661620691548,0.41476757050607116,0,0,2.3436686390532544,2.444644221713126,HSPA8
ERBB signaling pathway (GO:0038127),1/66,0.3523661620691548,0.41476757050607116,0,0,2.3436686390532544,2.444644221713126,HSP90AA1
extracellular matrix disassembly (GO:0022617),1/66,0.3523661620691548,0.41476757050607116,0,0,2.3436686390532544,2.444644221713126,BSG
positive regulation of T cell proliferation (GO:0042102),1/66,0.3523661620691548,0.41476757050607116,0,0,2.3436686390532544,2.444644221713126,TFRC
protein N-linked glycosylation (GO:0006487),1/67,0.3566222013839577,0.41867070390946176,0,0,2.308041958041958,2.379772017624197,STT3B
positive regulation of catabolic process (GO:0009896),1/67,0.3566222013839577,0.41867070390946176,0,0,2.308041958041958,2.379772017624197,OAZ1
vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.3566222013839577,0.41867070390946176,0,0,2.308041958041958,2.379772017624197,HSP90AA1
cellular protein modification process (GO:0006464),8/1025,0.35738275821932936,0.41919522825375244,0,0,1.2056502865913614,1.240551354240085,CDK6;WNK1;STRADB;PIM1;STT3B;HIPK1;FBXO7;UBA52
regulation of myeloid cell differentiation (GO:0045637),1/68,0.3608504834564241,0.4225208114792135,0,0,2.2734787600459243,2.3173377567270332,CDK6
positive regulation of protein localization to nucleus (GO:1900182),1/68,0.3608504834564241,0.4225208114792135,0,0,2.2734787600459243,2.3173377567270332,TFRC
negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.36353730577113685,0.42492199519705937,0,0,1.58890503875969,1.6077706769825337,HSP90AB1;OPTN
cellular response to tumor necrosis factor (GO:0071356),2/194,0.36353730577113685,0.42492199519705937,0,0,1.58890503875969,1.6077706769825337,FOXO3;YBX3
negative regulation of cellular catabolic process (GO:0031330),1/69,0.36505118796267055,0.42520347612740006,0,0,2.2399321266968326,2.257219237966515,EIF4G2
cellular response to calcium ion (GO:0071277),1/69,0.36505118796267055,0.42520347612740006,0,0,2.2399321266968326,2.257219237966515,DMTN
positive regulation of protein polymerization (GO:0032273),1/69,0.36505118796267055,0.42520347612740006,0,0,2.2399321266968326,2.257219237966515,HSP90AA1
positive regulation of protein transport (GO:0051222),1/69,0.36505118796267055,0.42520347612740006,0,0,2.2399321266968326,2.257219237966515,OAZ1
protein localization to membrane (GO:0072657),2/195,0.3658918738582209,0.4258114490196717,0,0,1.5805920392015103,1.5891547635586762,BSG;ANK1
carbohydrate homeostasis (GO:0033500),1/70,0.3692244932955234,0.42819784986355847,0,0,2.2073578595317724,2.1993019679968873,ADIPOR1
neutrophil chemotaxis (GO:0030593),1/70,0.3692244932955234,0.42819784986355847,0,0,2.2073578595317724,2.1993019679968873,BSG
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.3692244932955234,0.42819784986355847,0,0,2.2073578595317724,2.1993019679968873,DMTN
fatty acid catabolic process (GO:0009062),1/70,0.3692244932955234,0.42819784986355847,0,0,2.2073578595317724,2.1993019679968873,LPIN2
protein tetramerization (GO:0051262),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,SNCA
regulation of endopeptidase activity (GO:0052548),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,GAPDH
cellular response to BMP stimulus (GO:0071773),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,DDX5
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,CDK6
fatty acid biosynthetic process (GO:0006633),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,SCD
gland development (GO:0048732),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,MSN
response to metal ion (GO:0010038),1/71,0.3733705769010774,0.4303909324761341,0,0,2.1757142857142857,2.1434785738462874,SNCA
positive regulation of cytokine production (GO:0001819),3/335,0.37633646812889254,0.4328979618571045,0,0,1.3792121611445782,1.34786497710592,G3BP1;GAPDH;HSPD1
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.37748961494275957,0.4328979618571045,0,0,2.144962080173348,2.089648271564957,CDK6
cell junction organization (GO:0034330),1/72,0.37748961494275957,0.4328979618571045,0,0,2.144962080173348,2.089648271564957,SNCA
cytoskeleton-dependent cytokinesis (GO:0061640),1/72,0.37748961494275957,0.4328979618571045,0,0,2.144962080173348,2.089648271564957,SEPTIN6
response to ionizing radiation (GO:0010212),1/72,0.37748961494275957,0.4328979618571045,0,0,2.144962080173348,2.089648271564957,MYC
positive regulation of secretion by cell (GO:1903532),1/72,0.37748961494275957,0.4328979618571045,0,0,2.144962080173348,2.089648271564957,SNCA
ncRNA processing (GO:0034470),2/201,0.3799484341002059,0.435344003394404,0,0,1.5324685442717463,1.4830000538742525,HNRNPA2B1;UBA52
negative regulation of cell adhesion (GO:0007162),1/73,0.3815817824645011,0.43534864335830353,0,0,2.1150641025641024,2.037716378427825,DMTN
regulation of actin filament-based process (GO:0032970),1/73,0.3815817824645011,0.43534864335830353,0,0,2.1150641025641024,2.037716378427825,DMTN
defense response to Gram-negative bacterium (GO:0050829),1/73,0.3815817824645011,0.43534864335830353,0,0,2.1150641025641024,2.037716378427825,OPTN
granulocyte chemotaxis (GO:0071621),1/73,0.3815817824645011,0.43534864335830353,0,0,2.1150641025641024,2.037716378427825,BSG
response to molecule of bacterial origin (GO:0002237),1/73,0.3815817824645011,0.43534864335830353,0,0,2.1150641025641024,2.037716378427825,SNCA
positive regulation of immune response (GO:0050778),1/75,0.3896862007199225,0.4438369685948989,0,0,2.0576923076923075,1.9391969628488115,RIOK3
positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.3896862007199225,0.4438369685948989,0,0,2.0576923076923075,1.9391969628488115,TFRC
actomyosin structure organization (GO:0031032),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,EPB41
cellular response to hormone stimulus (GO:0032870),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,NCOA4
chloride transport (GO:0006821),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,SLC4A1
phospholipid metabolic process (GO:0006644),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,PIP4K2A
regulation of T cell proliferation (GO:0042129),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,TFRC
positive regulation of growth (GO:0045927),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,EIF4G2
positive regulation of interleukin-6 production (GO:0032755),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,HSPD1
RNA transport (GO:0050658),1/76,0.3936987960431698,0.4451920545354051,0,0,2.030153846153846,1.8924467629967627,HNRNPA2B1
regulation of protein kinase B signaling (GO:0051896),2/207,0.3938750063329707,0.4451920545354051,0,0,1.4871620344110419,1.3856210835932536,HSP90AA1;HSP90AB1
neutrophil migration (GO:1990266),1/77,0.39768520999592366,0.4483607093287376,0,0,2.0033400809716597,1.847268902960126,BSG
phosphatidylcholine metabolic process (GO:0046470),1/77,0.39768520999592366,0.4483607093287376,0,0,2.0033400809716597,1.847268902960126,LPIN2
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.39768520999592366,0.4483607093287376,0,0,2.0033400809716597,1.847268902960126,UBB
negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.40164561203881466,0.4516822707776569,0,0,1.9772227772227773,1.8035932383434459,BCL2L1
protein modification process (GO:0036211),1/78,0.40164561203881466,0.4516822707776569,0,0,1.9772227772227773,1.8035932383434459,UBA52
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),1/78,0.40164561203881466,0.4516822707776569,0,0,1.9772227772227773,1.8035932383434459,LNPEP
cellular response to DNA damage stimulus (GO:0006974),3/350,0.40289421639029155,0.4527053600483007,0,0,1.3185788904899136,1.1986953352289267,NPM1;MYC;BCL2L1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.4094890533403055,0.45754799030175364,0,0,1.9269717624148004,1.720487310971666,BCL2L1
regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.4094890533403055,0.45754799030175364,0,0,1.9269717624148004,1.720487310971666,ADIPOR1
regulation of organelle organization (GO:0033043),1/80,0.4094890533403055,0.45754799030175364,0,0,1.9269717624148004,1.720487310971666,MSN
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.4094890533403055,0.45754799030175364,0,0,1.9269717624148004,1.720487310971666,BCL2L1
skin development (GO:0043588),1/80,0.4094890533403055,0.45754799030175364,0,0,1.9269717624148004,1.720487310971666,TXNIP
lipid biosynthetic process (GO:0008610),1/80,0.4094890533403055,0.45754799030175364,0,0,1.9269717624148004,1.720487310971666,SCD
ubiquitin-dependent protein catabolic process (GO:0006511),3/354,0.40992652638264426,0.45754799030175364,0,0,1.3032852564102564,1.1622402582941644,UBE2H;RNF11;FBXO7
positive regulation of protein modification process (GO:0031401),2/214,0.40994382065209517,0.45754799030175364,0,0,1.4375457071815123,1.2819100389414764,HSP90AA1;TFRC
negative regulation of protein modification process (GO:0031400),1/81,0.41337242618858927,0.4609896171852715,0,0,1.9027884615384616,1.6809353792517892,FKBP8
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.41723045440387496,0.46451657256964746,0,0,1.8792022792022791,1.6426418344463662,CCNI
positive regulation of protein ubiquitination (GO:0031398),1/82,0.41723045440387496,0.46451657256964746,0,0,1.8792022792022791,1.6426418344463662,UBB
regulation of defense response (GO:0031347),1/83,0.42106330223634186,0.468393481921526,0,0,1.8561913696060037,1.6055537376823723,ERAP1
regulation of cytokinesis (GO:0032465),1/84,0.42487113264784415,0.47106044250416584,0,0,1.8337349397590361,1.569620947250916,BCL2L1
response to insulin (GO:0032868),1/84,0.42487113264784415,0.47106044250416584,0,0,1.8337349397590361,1.569620947250916,LPIN2
lymphocyte differentiation (GO:0030098),1/84,0.42487113264784415,0.47106044250416584,0,0,1.8337349397590361,1.569620947250916,CR2
vascular transport (GO:0010232),1/84,0.42487113264784415,0.47106044250416584,0,0,1.8337349397590361,1.569620947250916,TFRC
negative regulation of phosphorylation (GO:0042326),1/86,0.43241238866754017,0.47704620252669994,0,0,1.7904072398190045,1.5010336413104233,FKBP8
regulation of interferon-gamma production (GO:0032649),1/86,0.43241238866754017,0.47704620252669994,0,0,1.7904072398190045,1.5010336413104233,HSPD1
glucose homeostasis (GO:0042593),1/86,0.43241238866754017,0.47704620252669994,0,0,1.7904072398190045,1.5010336413104233,ADIPOR1
positive regulation of endothelial cell migration (GO:0010595),1/86,0.43241238866754017,0.47704620252669994,0,0,1.7904072398190045,1.5010336413104233,ATP5F1B
response to interleukin-1 (GO:0070555),1/86,0.43241238866754017,0.47704620252669994,0,0,1.7904072398190045,1.5010336413104233,SNCA
transport across blood-brain barrier (GO:0150104),1/86,0.43241238866754017,0.47704620252669994,0,0,1.7904072398190045,1.5010336413104233,TFRC
positive regulation of neuron projection development (GO:0010976),1/88,0.4398555062916063,0.4848572247570842,0,0,1.7490716180371353,1.436528262928994,CAPRIN1
regulation of endothelial cell migration (GO:0010594),1/89,0.4435406599599452,0.4877121989353801,0,0,1.7291083916083916,1.4057059898196773,GLUL
positive regulation of inflammatory response (GO:0050729),1/89,0.4435406599599452,0.4877121989353801,0,0,1.7291083916083916,1.4057059898196773,SNCA
protein import (GO:0017038),1/89,0.4435406599599452,0.4877121989353801,0,0,1.7291083916083916,1.4057059898196773,HSP90AA1
cellular amino acid catabolic process (GO:0009063),1/90,0.4472017530075081,0.49052671758459016,0,0,1.7095937770095073,1.3757877914896541,GLUL
positive regulation of binding (GO:0051099),1/90,0.4472017530075081,0.49052671758459016,0,0,1.7095937770095073,1.3757877914896541,EPB41
protein complex oligomerization (GO:0051259),1/90,0.4472017530075081,0.49052671758459016,0,0,1.7095937770095073,1.3757877914896541,SNCA
regulation of actin cytoskeleton organization (GO:0032956),1/91,0.45083894134441127,0.4937055947837159,0,0,1.6905128205128206,1.346738785032599,DMTN
positive regulation of transport (GO:0051050),1/91,0.45083894134441127,0.4937055947837159,0,0,1.6905128205128206,1.346738785032599,SNCA
negative regulation of mitotic cell cycle phase transition (GO:1901991),1/92,0.45445237990743537,0.4960362578074621,0,0,1.6718512256973797,1.318525774673755,CDK6
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.45445237990743537,0.4960362578074621,0,0,1.6718512256973797,1.318525774673755,DMTN
positive regulation of cellular component biogenesis (GO:0044089),1/92,0.45445237990743537,0.4960362578074621,0,0,1.6718512256973797,1.318525774673755,TFRC
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),1/92,0.45445237990743537,0.4960362578074621,0,0,1.6718512256973797,1.318525774673755,HSP90AB1
negative regulation of MAPK cascade (GO:0043409),1/94,0.46160862222211885,0.503436015745919,0,0,1.6357320099255583,1.2644828133338064,MYC
ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.4651517307541396,0.5068863884890135,0,0,1.6182487725040917,1.2385940558980708,HSP90AA1
translational termination (GO:0006415),1/96,0.4686716991821424,0.5103059414077769,0,0,1.6011336032388663,1.2134235161728557,GSPT1
protein maturation (GO:0051604),1/97,0.47216867746164864,0.5132769349786513,0,0,1.584375,1.1889450868592453,HSPD1
calcium ion homeostasis (GO:0055074),1/97,0.47216867746164864,0.5132769349786513,0,0,1.584375,1.1889450868592453,SNCA
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.47564281459284896,0.5166331709723953,0,0,1.5679619349722442,1.1651338487722471,CANX
sensory perception of chemical stimulus (GO:0007606),1/99,0.4790942585697632,0.5195372803970809,0,0,1.5518838304552591,1.141966005927008,GNAS
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),1/99,0.4790942585697632,0.5195372803970809,0,0,1.5518838304552591,1.141966005927008,HNRNPA2B1
calcium-mediated signaling (GO:0019722),1/102,0.4893138983023021,0.5284748327662697,0,0,1.5055597867479056,1.0761004785095143,DMTN
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),1/102,0.4893138983023021,0.5284748327662697,0,0,1.5055597867479056,1.0761004785095143,HSP90AB1
regulation of protein catabolic process (GO:0042176),1/102,0.4893138983023021,0.5284748327662697,0,0,1.5055597867479056,1.0761004785095143,OAZ1
positive regulation of cell growth (GO:0030307),1/102,0.4893138983023021,0.5284748327662697,0,0,1.5055597867479056,1.0761004785095143,EIF4G2
mitotic sister chromatid segregation (GO:0000070),1/102,0.4893138983023021,0.5284748327662697,0,0,1.5055597867479056,1.0761004785095143,SET
antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.49267603140886124,0.5316762342182865,0,0,1.4907239819004525,1.0552886617859483,CANX
positive regulation of phosphorylation (GO:0042327),2/253,0.49532507834872075,0.5341035550233179,0,0,1.2117730627876093,0.8513202690288773,HSP90AA1;TFRC
mRNA transport (GO:0051028),1/104,0.496016197552214,0.5344174515562563,0,0,1.4761762509335326,1.0350161016980663,HNRNPA2B1
positive regulation of cellular metabolic process (GO:0031325),1/105,0.4993345391220597,0.5375591815206058,0,0,1.4619082840236686,1.0152645867761303,SNCA
regulation of cell migration (GO:0030334),3/408,0.5018333343192029,0.5385046351583765,0,0,1.1263888888888889,0.776630741120196,TP53INP1;LDLRAD4;FOXO3
regulation of cell cycle process (GO:0010564),1/106,0.5026311976365985,0.5385046351583765,0,0,1.447912087912088,0.9960166740217915,BCL2L1
cellular response to peptide hormone stimulus (GO:0071375),1/106,0.5026311976365985,0.5385046351583765,0,0,1.447912087912088,0.9960166740217915,LPIN2
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.5026311976365985,0.5385046351583765,0,0,1.447912087912088,0.9960166740217915,PIP4K2A
RNA export from nucleus (GO:0006405),1/106,0.5026311976365985,0.5385046351583765,0,0,1.447912087912088,0.9960166740217915,HNRNPA2B1
positive regulation of protein serine/threonine kinase activity (GO:0071902),1/106,0.5026311976365985,0.5385046351583765,0,0,1.447912087912088,0.9960166740217915,SNCA
positive regulation of cell differentiation (GO:0045597),2/258,0.5057059117502072,0.5407126680054851,0,0,1.1878028100775193,0.8098439330251682,HSP90AB1;BTG1
response to calcium ion (GO:0051592),1/107,0.5059063136278865,0.5407126680054851,0,0,1.434179970972424,0.9772556502230401,DMTN
mRNA export from nucleus (GO:0006406),1/107,0.5059063136278865,0.5407126680054851,0,0,1.434179970972424,0.9772556502230401,HNRNPA2B1
"positive regulation of transcription, DNA-templated (GO:0045893)",8/1183,0.5150539828193271,0.5493195182933894,0,0,1.0347829095312229,0.6865614515437787,RNF10;NPM1;UBB;MYC;TP53INP1;FOXO3;UBA52;LPIN2
regulation of interleukin-6 production (GO:0032675),1/110,0.5156037993562202,0.5493195182933894,0,0,1.3944954128440368,0.9237369646702739,HSPD1
regulation of protein kinase activity (GO:0045859),1/110,0.5156037993562202,0.5493195182933894,0,0,1.3944954128440368,0.9237369646702739,SNCA
response to tumor necrosis factor (GO:0034612),1/110,0.5156037993562202,0.5493195182933894,0,0,1.3944954128440368,0.9237369646702739,YBX3
cellular protein metabolic process (GO:0044267),3/417,0.5164685732768534,0.5498024015122519,0,0,1.1013926630434783,0.727735110944813,RPS26;UBA52;GSPT1
protein-containing complex subunit organization (GO:0043933),1/112,0.5219636146933403,0.5543270184660594,0,0,1.3692307692307693,0.8902155130639214,DMTN
regulation of cytoskeleton organization (GO:0051493),1/112,0.5219636146933403,0.5543270184660594,0,0,1.3692307692307693,0.8902155130639214,DMTN
phosphatidylinositol metabolic process (GO:0046488),1/112,0.5219636146933403,0.5543270184660594,0,0,1.3692307692307693,0.8902155130639214,PIP4K2A
protein-containing complex assembly (GO:0065003),2/267,0.5240429035833148,0.5556518406248482,0,0,1.1469357905514115,0.7411289429524347,DMTN;MYC
negative regulation of signal transduction (GO:0009968),2/267,0.5240429035833148,0.5556518406248482,0,0,1.1469357905514115,0.7411289429524347,PIP4K2A;SNCA
activation of protein kinase activity (GO:0032147),1/114,0.5282405585345831,0.559658514038226,0,0,1.344860449285228,0.8582946400248314,STRADB
cellular response to molecule of bacterial origin (GO:0071219),1/115,0.531348289012283,0.5625050032649843,0,0,1.332995951417004,0.8429034090688156,VIM
tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.5344357024328013,0.5653254936264627,0,0,1.3213377926421406,0.8278760684748477,FOXO3
positive regulation of cell projection organization (GO:0031346),1/117,0.5375029306097294,0.56812018615079,0,0,1.3098806366047746,0.813201494064047,CAPRIN1
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),1/118,0.540550104467156,0.5704383408910905,0,0,1.2986193293885602,0.7988689854731565,GNAS
regulation of protein binding (GO:0043393),1/118,0.540550104467156,0.5704383408910905,0,0,1.2986193293885602,0.7988689854731565,EPB41
plasma membrane bounded cell projection assembly (GO:0120031),2/278,0.5458330226388192,0.5755587357896309,0,0,1.1006066734074822,0.6663536919514723,DMTN;SEPTIN6
cellular response to lipopolysaccharide (GO:0071222),1/120,0.5465848087934013,0.5758969278769592,0,0,1.2766645119586295,0.7711893672663548,VIM
cellular response to interferon-gamma (GO:0071346),1/121,0.5495725970000418,0.5785886442805799,0,0,1.2659615384615384,0.7578228057755461,GAPDH
positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.5554896837382342,0.5843576515545519,0,0,1.2450819672131148,0.7319902142521676,MYC
proteolysis (GO:0006508),2/287,0.5631430076839138,0.5907517462297106,0,0,1.065361077111383,0.6117534200498848,ERAP1;LNPEP
negative regulation of cell growth (GO:0030308),1/126,0.5642209791834661,0.5907517462297106,0,0,1.2150153846153846,0.6953646008048276,BTG1
negative regulation of growth (GO:0045926),1/126,0.5642209791834661,0.5907517462297106,0,0,1.2150153846153846,0.6953646008048276,BTG1
circulatory system development (GO:0072359),1/126,0.5642209791834661,0.5907517462297106,0,0,1.2150153846153846,0.6953646008048276,MICAL2
phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.5642209791834661,0.5907517462297106,0,0,1.2150153846153846,0.6953646008048276,PIP4K2A
synapse organization (GO:0050808),1/126,0.5642209791834661,0.5907517462297106,0,0,1.2150153846153846,0.6953646008048276,SNCA
cellular response to insulin stimulus (GO:0032869),1/129,0.5727820531517377,0.5987768568159011,0,0,1.186358173076923,0.6610980867446018,LPIN2
muscle contraction (GO:0006936),1/129,0.5727820531517377,0.5987768568159011,0,0,1.186358173076923,0.6610980867446018,VIM
regulation of response to external stimulus (GO:0032101),1/130,0.5755984885948349,0.5998436667415752,0,0,1.1771019677996422,0.6501663037283449,ERAP1
positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.5755984885948349,0.5998436667415752,0,0,1.1771019677996422,0.6501663037283449,WNK1
Golgi organization (GO:0007030),1/130,0.5755984885948349,0.5998436667415752,0,0,1.1771019677996422,0.6501663037283449,OPTN
protein glycosylation (GO:0006486),1/130,0.5755984885948349,0.5998436667415752,0,0,1.1771019677996422,0.6501663037283449,STT3B
regulation of cell motility (GO:2000145),1/133,0.583937712878072,0.6080598475487952,0,0,1.1501748251748252,0.618749150672192,CDK6
organic substance transport (GO:0071702),1/136,0.5921143023385672,0.616094009286858,0,0,1.1244444444444444,0.5892713905269606,TXNIP
chemical synaptic transmission (GO:0007268),2/306,0.5981312398384342,0.6218703007191815,0,0,0.9978070175438597,0.5128180119438517,HSPA8;SNCA
neuron projection morphogenesis (GO:0048812),1/140,0.6027688662081692,0.6262046697154853,0,0,1.0918649695628113,0.5527254814058667,UBB
regulation of small GTPase mediated signal transduction (GO:0051056),1/141,0.6053890631687141,0.6284380640197375,0,0,1.084010989010989,0.5440477148626345,ARHGEF12
Ras protein signal transduction (GO:0007265),1/142,0.6079921078772653,0.6306501988540578,0,0,1.0762684124386253,0.5355440345121155,G3BP1
negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.6105781118317544,0.631371793658842,0,0,1.06863488624052,0.5272100019777649,PIM1
neuron development (GO:0048666),1/143,0.6105781118317544,0.631371793658842,0,0,1.06863488624052,0.5272100019777649,WNK1
nitrogen compound transport (GO:0071705),1/143,0.6105781118317544,0.631371793658842,0,0,1.06863488624052,0.5272100019777649,TXNIP
monocarboxylic acid metabolic process (GO:0032787),1/143,0.6105781118317544,0.631371793658842,0,0,1.06863488624052,0.5272100019777649,BSG
cilium assembly (GO:0060271),2/314,0.6122278060658481,0.6325880501964215,0,0,0.971824686940966,0.47682659275798694,HSP90AA1;SEPTIN6
positive regulation of intracellular protein transport (GO:0090316),1/148,0.6232563692479988,0.6434857104446108,0,0,1.0320251177394035,0.48793872761087054,OAZ1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/149,0.625742428299264,0.645055466209735,0,0,1.025,0.4805368601680079,HSP90AA1
positive regulation of hydrolase activity (GO:0051345),1/149,0.625742428299264,0.645055466209735,0,0,1.025,0.4805368601680079,DOCK8
regulation of cytokine production (GO:0001817),1/150,0.6282122067872935,0.6471021652026401,0,0,1.0180691791430045,0.4732772111983408,GAPDH
actin filament organization (GO:0007015),1/152,0.6331033440283869,0.6516379565654274,0,0,1.0044829342842587,0.4591708555902901,DMTN
positive regulation of Wnt signaling pathway (GO:0030177),1/153,0.6355249124726667,0.6536268537825117,0,0,0.9978238866396761,0.45231754688375897,WNK1
cellular protein localization (GO:0034613),2/329,0.6376450304306407,0.6553028928117969,0,0,0.9265343858900505,0.41691594745953947,NPM1;SEPTIN6
skeletal system development (GO:0001501),1/158,0.6473968833781079,0.6643027927750784,0,0,0.9658010779029887,0.41992620552499144,GNAS
T cell receptor signaling pathway (GO:0050852),1/158,0.6473968833781079,0.6643027927750784,0,0,0.9658010779029887,0.41992620552499144,WNK1
rRNA metabolic process (GO:0016072),1/162,0.6566174919343953,0.6732470984070239,0,0,0.9416149068322981,0.3960937324830159,UBA52
heart development (GO:0007507),1/164,0.6611376589482784,0.677361895977684,0,0,0.9299669655497876,0.3848140086081573,MICAL2
post-translational protein modification (GO:0043687),2/345,0.6633109061896433,0.6786138848849318,0,0,0.8825909101182001,0.36231368333155756,STT3B;FBXO7
regulation of neuron projection development (GO:0010975),1/165,0.6633755491464977,0.6786138848849318,0,0,0.924249530956848,0.3793249562659222,FBXO7
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/170,0.6743468892721798,0.6893094445812029,0,0,0.8966772872098316,0.3533003810089062,BSG
neuron projection development (GO:0031175),1/171,0.6764981942916616,0.6909798070135015,0,0,0.8913574660633484,0.3483652278581477,UBB
neuron differentiation (GO:0030182),1/174,0.6828678513134807,0.6969529788806801,0,0,0.8757670075589151,0.3340647587713552,WNK1
defense response to bacterium (GO:0042742),1/176,0.687044984441584,0.7006809917663788,0,0,0.8656703296703296,0.32493412753727646,OPTN
regulation of immune response (GO:0050776),1/179,0.6932085209849612,0.7064276003325005,0,0,0.8509507346585998,0.31180913702903773,ERAP1
regulated exocytosis (GO:0045055),1/180,0.695236143263165,0.7079538775911497,0,0,0.8461538461538461,0.30758006793313236,SNCA
regulation of transcription by RNA polymerase II (GO:0006357),13/2206,0.6982652841707583,0.7104968923473975,0,0,0.8879872011871363,0.31892609563474134,RNF10;DDX5;NPM1;FOXO3;HSPD1;HNRNPK;UBB;MYC;MXI1;HDGF;UBA52;LPIN2;SNCA
antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.7051764887603402,0.7169830966391282,0,0,0.8229515050167224,0.28746286030360146,WNK1
"regulation of transcription, DNA-templated (GO:0006355)",13/2244,0.7216010685613226,0.7331247358159141,0,0,0.8709858769723997,0.28418773631695854,HSPA8;RNF10;DDX5;NPM1;SET;BTG1;FOXO3;HSPD1;HNRNPK;MYC;TP53INP1;MXI1;HDGF
endomembrane system organization (GO:0010256),1/199,0.7313301361490929,0.7424445759081977,0,0,0.7642191142191143,0.23911674680119524,OPTN
generation of neurons (GO:0048699),1/202,0.7366275930715562,0.7472547185600601,0,0,0.7526980482204363,0.2300793317146151,CDK6
regulation of inflammatory response (GO:0050727),1/206,0.7435299523592882,0.7536843826646502,0,0,0.7378611632270169,0.2186623727109167,SNCA
phosphate-containing compound metabolic process (GO:0006796),1/212,0.7535482869954573,0.7632604332266346,0,0,0.7166605905942399,0.2027878425795981,PIP4K2A
positive regulation of GTPase activity (GO:0043547),1/214,0.7568006543855508,0.7659739956508302,0,0,0.7098591549295775,0.19780608432609348,DOCK8
extracellular structure organization (GO:0043062),1/216,0.7600104240085657,0.7686403682630157,0,0,0.7031842576028623,0.1929700249346418,BSG
external encapsulating structure organization (GO:0045229),1/217,0.7615995079315602,0.7696648582424845,0,0,0.6998931623931623,0.1906050135624194,BSG
cilium organization (GO:0044782),1/228,0.778405000638495,0.7860537270242096,0,0,0.665604879701796,0.16673956277913388,SEPTIN6
anterograde trans-synaptic signaling (GO:0098916),1/244,0.800771891238226,0.8080296425183308,0,0,0.6212725546058879,0.13803380962187647,SNCA
negative regulation of nucleic acid-templated transcription (GO:1903507),2/464,0.8110630385850923,0.8172169284833345,0,0,0.6512634652169536,0.13638075560083404,HSPA8;SET
positive regulation of signal transduction (GO:0009967),1/252,0.811100035306064,0.8172169284833345,0,0,0.6012258657676984,0.12587498264518154,DMTN
regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.8123531082693667,0.8178626621310279,0,0,0.5988095238095238,0.12444469760159665,WNK1
regulation of cellular macromolecule biosynthetic process (GO:2000112),2/468,0.8148495446172644,0.819758276813754,0,0,0.6455401403999068,0.13217549966072323,BTG1;FOXO3
cellular component assembly (GO:0022607),1/261,0.8220851982590914,0.8264152181144816,0,0,0.5801479289940829,0.1136575011852373,DMTN
positive regulation of cell migration (GO:0030335),1/269,0.8313161928500263,0.8350664914643874,0,0,0.5626004592422503,0.10393765542215962,DMTN
inorganic cation transmembrane transport (GO:0098662),1/274,0.8368425373301357,0.8399861982517364,0,0,0.5521555367709214,0.09834958731503575,ATP5F1B
extracellular matrix organization (GO:0030198),1/300,0.8628100981128426,0.8654011194284968,0,0,0.5034731155132492,0.0742928255444593,BSG
transcription by RNA polymerase II (GO:0006366),1/320,0.8799552877005353,0.8819356821964855,0,0,0.4714251265975404,0.06028781679851412,DDX5
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/404,0.9315796404187614,0.932976311543827,0,0,0.3715594579118152,0.02633375477424982,HSP90AA1
regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.942535353273107,0.9432413722643228,0,0,0.34857450242065624,0.020629284006492037,BTG1
nervous system development (GO:0007399),1/447,0.9487380735948187,0.9487380735948187,0,0,0.3349948258020007,0.017628272256446437,TRAK2
